MCiM Community

Marcia Cohen, MBA

Marcia Cohen is the Senior Associate Dean for Finance and Administration

for the Stanford University School of Medicine, a position she has held since 2006. Reporting to the Dean, Marcia is responsible for the oversight and direction of strategy and operations of the School’s financial, administrative, and information technology functions. She has financial oversight for the School’s $2.0 billion budget, and sets financial and administrative policy for the School, including its 27 academic departments and 8 interdisciplinary institutes and centers.

Prior to joining Stanford in 2003, Ms. Cohen served as the Director of Finance in the Department of Medicine at the University of California, San Francisco (UCSF). Prior to UCSF, Marcia was a management consultant with Touche Ross (now Deloitte) including 5 years based in Hong Kong. Marcia graduated with a B.A. magna cum laude, majoring in Economics, from Carleton College and holds an MBA from the Yale University School of Management.

Less

Stanford Profile

Charles "Chuck" Eesley, PhD

Chuck Eesley is an Associate Professor and W.M. Keck Foundation Faculty Scholar in the Department of

Management Science and Engineering at Stanford University. As part of the Stanford Technology Ventures Program, his research focuses on the role of the institutional and university environment in high-growth, technology entrepreneurship. His research focuses on rethinking how the educational and policy environment shapes the economic and entrepreneurial impact of university alumni. His field research spans China, Japan, Chile, Bangladesh, Thailand and Silicon Valley and has received awards from the Schulze Foundation, the Technical University of Munich, and the Kauffman Foundation. He is a faculty affiliate at the Stanford Center for International Development, the Woods Institute for the Environment and the Stanford King Center on Global Development. He is also a member of the Editorial Board for the Strategic Management Journal. Before coming to Stanford, Prof. Eesley completed his Ph.D. at the M.I.T. Sloan School of Management. He started his first company while earning a Bachelor's degree from Duke University in 2002. His work has been published among other places in Organization Science, Strategic Management Journal, Research Policy, and Biological Psychiatry. Prof. Eesley previously was an entrepreneur, early employee, board member/advisor, and investor in the areas of life sciences, online education and machine learning. He has also been an advocate and mentor for immigrants and historically under-represented groups in STEM, academia and the tech sector via programs such as Diversifying Academia, Recognizing Excellence (DARE), Global Innovation through Science and Technology (GIST), and SURF among others. When not occupied with his Stanford responsibilities, Eesley is actively involved as a co-founder, board member and angel investor in many high-tech start-ups.

Less

Stanford Profile

Robert Harrington, MD

Dr. Robert A. Harrington is an interventional cardiologist and the Arthur L. Bloomfield Professor

of Medicine and Chairman of the Department of Medicine at Stanford University. Dr. Harrington was previously the Richard Sean Stack, MD Distinguished Professor and the Director of the Duke Clinical Research Institute (DCRI) at Duke University. His research interests include evaluating antithrombotic therapies to treat acute ischemic heart disease and to minimize the acute complications of percutaneous coronary procedures, studying the mechanism of disease of the acute coronary syndromes, understanding the issue of risk stratification in the care of patients with acute ischemic coronary syndromes, building local, national and international collaborations for the efficient conduct of innovative clinical research and trying to better understand and improve upon the methodology of clinical research. His research has been extensively funded through NIH, NIA, other peer reviewed agencies and private industry. Committed to training and mentorship, Harrington has served as the principal mentor for more than 20 post-doctoral clinical research fellows focused on cardiovascular research.

He has authored more than 640 peer-reviewed manuscripts, reviews, book chapters, and editorials. Thomson Reuters lists him as one of the most cited investigators in clinical medicine from 2002-2014. He is a deputy editor of JAMA Cardiology and an editorial board member for the Journal of the American College of Cardiology. He has served as editor of five textbooks and is a senior editor of the 13th and 14th editions of Hurst’s The Heart, one of the leading textbooks of cardiovascular medicine. He has been a member of the NHLBI’s Clinical Trials Study Section and the IOM’s Working Group on Data Sharing. He served as a member of the NIH NCATS Advisory Council Working Group on the IOM CTSA Program. He recently served a second term as a member and the chair of the US Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee.

Harrington was recently a member of the American College of Cardiology (ACC) Board of Trustees and is currently a member of the American Heart Association’s (AHA) Board of Directors, its Science Advisory and Coordinating Committee, and its President-elect. He will serve as the AHA President beginning in July 2019. He served as the Chair for the AHA’s Scientific Sessions in 2013 and 2014. Harrington is a Fellow of the American College of Cardiology, the American Heart Association, the Society for Cardiac Angiography and Intervention, the European Society of Cardiology, the American College of Chest Physicians and the American College of Physicians. He is an elected member of the Association of American Physicians and the Association of University Cardiologists. In 2015, he was elected to membership in the National Academy of Medicine/Institute of Medicine. In 2016, he was named a Master of the American College of Cardiology. He was awarded the AHA's Clinical Research Prize in 2017.

Harrington received his BA in English at the College of the Holy Cross, Worcester, MA. He attended Dartmouth Medical School and received his MD from Tufts University School of Medicine, Boston MA. He did his internship, residency and served as the chief resident in internal medicine at the University of Massachusetts Medical Center, Worcester MA. He trained in cardiology, interventional cardiology and clinical research (Duke Databank for Cardiovascular Disease) at Duke University Medical Center, Durham NC where he was a faculty member from 1993-2012 before joining the Stanford University faculty in 2012. Interested in innovative learning tools, including novel methods of communicating scientific information, Harrington hosts a regular podcast on theheart.org, The Bob Harrington Show, and can be followed on Twitter @HeartBobH.

Less

Stanford Profile

Lawrence “Rusty” Hofmann, MD

Dr. Lawrence “Rusty” Hofmann is the Chief of Interventional Radiology

at Stanford Hospital, a tenured Professor of Radiology at the Stanford School of Medicine, and a renowned expert in deep vein thromboses (DVTs). He and co-founder Owen Tripp started Grand Rounds with the goal of making expert medical care more broadly accessible.

Less

Stanford Profile

Arnold Milstein, MD, MPH

Dr. Arnold Milstein is Professor of Medicine and the Director of the Clinical Excellence Research Center.

The Center engages faculty from Health, Computer, and Social Sciences in the discovery and replication of innovative health care delivery methods that safely lower per capita health care spending for excellent care.

Before joining Stanford's faculty, his career of applied research spanned private and public sector healthcare delivery and policy. After creating a healthcare performance improvement firm that he expanded globally following its acquisition by Mercer, he co-founded three nationally influential public benefit initiatives, the Leapfrog Group in partnership with the Business Roundtable in 1998 and the Consumer Purchaser Alliance in 2001. Appointed to consecutive term as a Congressional MedPAC Commissioner, he originated two subsequently enacted legislative changes to improve the value of healthcare. He was a founding staff member and serves as the Medical Director of the Pacific Business Group on Health (PBGH), the largest employer-led regional healthcare improvement coalition in the U.S.

Citing his national impact on innovation in health care policy and delivery methods, he was selected for the highest annual award of both the National Business Group on Health (NBGH) and of the American College of Medical Quality. Elected to the Institute of Medicine (now, NAM) of the National Academy of Sciences, he chaired the planning committee of its workshop series on best methods to lower per capita health care spending and improve clinical outcomes. He was educated at Harvard (BA–Economics), Tufts (MD) and UC Berkeley (MPH Healthcare Evaluation).

Less

Stanford Profile

Natalie Pageler, MD

Dr. Natalie Pageler is a board-certified pediatric intensivist and board-certified clinical informaticist.

She is Chief Medical Information Officer of Stanford Children’s Health, Associate Program Director for the Stanford Clinical Informatics Fellowship, and an Associate Professor of Pediatric Critical Care at Stanford University School of Medicine.

Less

Stanford Profile

Kevin Schulman, MD, MBA

Dr. Schulman was appointed as Professor of Medicine, Associate Chair of Business Development and Strategy in the

Department of Medicine, Director of Industry Partnerships and Education for the Clinical Excellence Research Center (CERC) at the Stanford University School of Medicine, and, by courtesy, Professor of Economics at Stanford’s Graduate School of Business in June, 2018. Dr. Schulman is a Professor of Medicine, Clinical Excellence Research Center (CERC) at the Stanford University School of Medicine, and, by courtesy, Professor of Operations, Information and Technology at Stanford’s Graduate School of Business.

Dr. Schulman’s research interests include organizational innovation in health care, health care policy and health economics. With over 300 original articles, over 100 review articles/commentaries, and over 40 case studies/book chapters, Kevin Schulman has had a broad impact on health policy (h-index = 77). His peer-reviewed articles have appeared in the New England Journal of Medicine, JAMA, and Annals of Internal Medicine. He is a member of the editorial/advisory boards of the American Heart Journal, Health Policy, Management and Innovation (www.HMPI.Org), and Senior Associate Editor of Health Services Research.

Prior to coming to Stanford, Dr. Schulman served as a Professor of Medicine at Duke University, directed the Health Sector Management Program at Duke’s Fuqua School of Business for a dozen years, created and directed the Duke University Master’s of Management in Clinical Informatics Program, and served as a Visiting Professor and Visiting Scholar at Harvard Business School.

He is a co-founder of Bivarus (exit January, 2018), co-founder and Managing Member of Faculty Connection, LLC., and is a Board Member of Grid Therapeutics.

He is an elected member of ASCI and AAP.

He is a graduate of Dartmouth College, the New York University School of Medicine, and The Wharton Health Care Management Program.

Less

Stanford Profile

Nigam H. Shah, MBBS, PhD

Dr. Nigam Shah is Professor of Medicine (Biomedical Informatics) at Stanford University,

Associate CIO for Data Science at Stanford Healthcare, and a member of the Biomedical Informatics Graduate Program as well as the Clinical Informatics Fellowship. Dr. Shah's research focuses on combining machine learning and prior knowledge in medical ontologies to enable use cases of the learning health system.

Dr. Shah received the AMIA New Investigator Award for 2013 and the Stanford Biosciences Faculty Teaching Award for outstanding teaching in his graduate class on “Data driven medicine”. Dr. Shah was elected into the American College of Medical Informatics (ACMI) in 2015 and is inducted into the American Society for Clinical Investigation (ASCI) in 2016. He holds an MBBS from Baroda Medical College, India, a PhD from Penn State University and completed postdoctoral training at Stanford University.

Less

Stanford Profile

Christopher Sharp, MD

Dr. Sharp serves as Chief Medical Information Officer for Stanford Health Care

with responsibility for driving the enhancement and expansion of clinical information systems to drive organizational strategic outcomes in quality, experience and value. Dr. Sharp is a practicing General Internal Medicine physician at Stanford. He holds board certifications in Internal Medicine and Clinical Informatics.

Less

Stanford Profile

Sara Singer, MBA, Ph.D

Dr. Singer is a faculty affiliate of Stanford’s Freeman Spogli Institute for International Studies,

the Center for Health Policy/Center for Primary Care and Outcomes Research, which she helped to found in 1999, the Center for Innovation in Global Health, the Clinical Excellence Research Center, and the Woods Institute for the Environment. She is also an adjunct professor at the Harvard Chan School of Public Health.

She served as principal investigator of numerous studies for the Agency for Healthcare Research and Quality, Veterans Administration Health Services Research & Development, and private foundations related to measuring and improving the financing and delivery of health care. Dr. Singer currently leads the AHRQ-funded Engineering High Reliability Learning Lab and the Center of Excellence in Health System Performance Project on Care Integration, the Robert Wood Johnson Foundation-funded initiatives on Corporations and Public Health and Culture of Health: A Business Leadership Imperative, and the Commonwealth Fund and Peterson Center on Health Care-supported program on serving patients with high needs.

An internationally respected scientist and award-winning teacher, Dr. Singer received the 2013 Avedis Donabedian Healthcare Quality Award from the American Public Health Association, 2013 Lewis W. Blackman Patient Safety Champion Award, 2014 Teaching Citation Award from the Harvard Chan School of Public Health, and the 2019 Sherman Award for Excellence in Patient Engagement. Her publications have won numerous awards, including Best Paper awards from the Academy of Management’s Health Care Division in 2009, 2010, 2011, and 2019 and from the Production and Operations Management Society College of Service Operations 2015-2016. She earned her MBA from Stanford University and her PhD from Harvard University in Health Policy and Management.

Less

Stanford Profile

Kristan Staudenmayer, MD, MS, FACS

Dr. Kristan Staudenmayer received her medical degree at the University of Texas at Southwestern Medical School in

1999, and completed her residency in General Surgery at Parkland Hospital in 2006. During her post-graduate training, she conducted NIH T32-funded research at Harborview Hospital evaluating the effects of innate immunity on trauma. She obtained further training in Trauma and Surgical Critical at San Francisco General Hospital, completing her training in 2008. She was subsequently double-boarded in General Surgery and Surgical Critical Care. Dr. Staudenmayer joined Stanford in 2008. She has developed a robust research program and active clinical practice. Her clinical and research interests have contributed to Stanford’s multi-disciplinary approach to the management of surgical trauma. Dr. Staudenmayer’s clinical focus is on trauma, emergency general surgery, and surgical critical care, and her research interests encompass trauma systems of care and vulnerable patient populations such as the elderly. Her efforts have been noteworthy and recognized in her 2013 K08 grant from the National Institute on Aging to study trauma in the elderly population. In 2016, Dr. Staudenmayer was honored by becoming the inaugural Gordon and Betty Moore Endowed Faculty Scholar, which helps to support her ongoing research efforts. Additional research accomplishments include being a co-principal investigator on an NIH CTSA award evaluating trauma systems. Dr. Staudenmayer has published over 50 articles and book chapters and has served on the editorial review board of several academic journals. She contributes nationally towards the academic mission by serving on committees for both the American Association for the Surgery of Trauma and the Eastern Association for the Surgery of Trauma. Dr. Staudenmayer was promoted to Associate Professor of Surgery in 2016, and continues her research, policy and advocacy work to improve the care and outcomes for patients with traumatic injuries and critical surgical illnesses.

Less

Stanford Profile

Blake Johnson, PhD

Blake Johnson, PhD, is an Adjunct Professor in the Department of Management Science and Engineering,

where he was previously a full-time faculty member. His work focuses on methods for proactively incorporating uncertainty about demand and supply in supply chain planning and performance management, both inside a company and in its relationships with key customers, suppliers and partners. Blake pioneered the development of business capabilities able to proactively manage the impact of demand and supply uncertainty on performance and supply chain planning and execution.

In 2000 he founded Vivecon, which delivered the first supply planning capabilities of this kind to leading companies in high tech, CPG, automotive and energy, with financing by Texas Pacific Group, Benchmark Capital and Foundational Capital.

In 2008 he began development of Aztral (which is privately financed) to provide a fully integrated set of capabilities spanning performance management, planning, and operational execution. Large-scale deployment of these capabilities began in 2016. Now validated and refined, they are being delivered through Aztral’s highly automated “self-driving” enterprise analytic capabilities, which ensure optimal performance and extremely efficient implementation.

Less

David Magnus, PhD

David Magnus, PhD is Thomas A. Raffin Professor of Medicine and Biomedical Ethics

and Professor of Pediatrics and Medicine and by Courtesy of Bioengineering at Stanford University, where he is Director of the Stanford Center for Biomedical Ethics and an Associate Dean of Research. Magnus is member of the Ethics Committee for the Stanford Hospital. He is currently the Vice-Chair of the IRB for the NIH Precision Medicine Initiative ("All of Us"). He is the former President of the Association of Bioethics Program Directors, and is the Editor in Chief of the American Journal of Bioethics. He has published articles on a wide range of topics in bioethics, including research ethics, genetics, stem cell research, organ transplantation, end of life, and patient communication. He was a member of the Secretary of Agriculture’s Advisory Committee on Biotechnology in the 21st Century and currently serves on the California Human Stem Cell Research Advisory Committee. He is the principal editor of a collection of essays entitled "Who Owns Life?" (2002) and his publications have appeared in New England Journal of Medicine, Science, Nature Biotechnology, and the British Medical Journal. He has appeared on many radio and television shows including 60 Minutes, Good Morning America, The Today Show, CBS This Morning, FOX news Sunday, and ABC World News and NPR. In addition to his scholarly work, he has published Opinion pieces in the Philadelphia Inquirer, the Chicago Tribune, the San Jose Mercury News, and the New Jersey Star Ledger.

Less

Stanford Profile

David Scheinker, PhD

David Scheinker is the Executive Director of Systems Design and Collaborative Research

at the Stanford Lucile Packard Children's Hospital. He is the Founder and Director of SURF Stanford Medicine, a group that brings together students and faculty from the university with physicians, nurses, and administrators from the hospitals. SURF has implemented and published dozens of projects demonstrating improvements to the quality and efficiency of care. His areas of focus include clinical care delivery, technical improvements to hospital operations, sensor-based and algorithm-enabled telemedicine, and the socioeconomic factors that shape healthcare cost and quality.

Before coming to Stanford, he was a Joint Research Fellow at The MIT Sloan School of Management and Massachusetts General Hospital. He received a PhD in theoretical math from The University of California San Diego under Jim Agler. His current areas of research include applications of operations research in healthcare, type 1 diabetes management with continuous glucose monitor data, and healthcare policy. He advises Carta Healthcare, a healthcare analytics company started by former students.

Less

Stanford Profile

Gordon Bloom, MBA, MFA

Gordon founded the Social Entrepreneurship Collaboratory (SE Labs) at Stanford,

Harvard and Princeton. He teaches about the design, development and leadership of innovative social ventures in global health and environmental sustainability.

At Stanford, Gordon is director of the Social Entrepreneurship and Innovation Lab (SE Lab)- Human & Planetary Health and is a faculty fellow of the Center for Innovation in Global Health. He is a Lecturer in the School of Medicine, Division of Primary Care and Population Health/Dept. of Medicine, an affiliate at the Center for Health Policy and the Center for Primary Care and Outcomes Research, Freeman Spogli Institute for International Studies, and a mentor in the Knight-Hennessy Scholars Program.

At Harvard, Gordon taught jointly on the faculties of the Harvard T. H. Chan School of Public Health (Health Policy & Management) and the Harvard Kennedy School (Management, Leadership & Decision Sciences) and served as an Expert-in-Residence (EiR) at the Harvard Innovation Lab (i-Lab), and affiliated faculty at the Center for Primary Care, Harvard Medical School (HMS). He was faculty director of the Social Entrepreneurship and Innovation Lab (SE Lab) for US & Global Health, an incubator course taught in a new interdisciplinary, collaborative model based at the i-Lab. He has also served as an Entrepreneur-in-Residence (2013-2014) at Harvard Business School in the Rock Center for Entrepreneurship, on the Faculty of Arts & Sciences in the Sociology Department, at the Harvard Kennedy School, on the Leadership & Management faculty, and as a principal of the Hauser Center for Non-Profit Organizations (2004-2007). Gordon served as one of the founding faculty of the $10 million Reynolds Fellows Program in Social Entrepreneurship, a Center for Public Leadership and Harvard President’s interdisciplinary fellowship initiative that paid full tuition and stipend for graduate students from the Harvard Kennedy School, School of Public Health and Graduate School of Education.

At Princeton, Gordon served as Dean’s Visiting Professor in Entrepreneurship in 2009-2010. Working together with the School of Engineering & Applied Science, the Woodrow Wilson School of Public & International Affairs, and the Faculty of Arts & Sciences, he launched a new set of programs and prizes in social innovation and entrepreneurship in collaboration with students, faculty and alumni.

At Stanford in 2001-2002, Gordon created the SE Lab, a Silicon Valley and technology–influenced, interdisciplinary incubator for social ventures and global problem solving. Gordon taught on the Public Policy Program and Urban Studies faculties (School of Humanities & Sciences) and served as a faculty affiliate at the Center for Social Innovation at Stanford Graduate School of Business, and a Program Officer at Stanford’s Freeman Spogli Institute for International Studies.

Many of the talented students and fellows in Gordon’s SE Labs have won the top awards of prestigious idea and business plan competitions, including those at Stanford, Harvard, Princeton and MIT.

Gordon is an author in the edited volume Social Entrepreneurship: New Models of Sustainable Social Change (A. Nicholls, ed., Yunus, Drayton et. al., Oxford University Press, 2006/2008) and served as a founding member of the Oxford/Ashoka led University Network for Social Entrepreneurship. His interest in entrepreneurship is informed by work in both the private and nonprofit sectors in the U.S. (New York, Cambridge, Palo Alto), Europe (London, Paris) and Asia (Hong Kong), as CEO of a medical technology company and in international strategy consulting.

Gordon is married to Sara Singer- they on occasion teach together at Stanford, have a daughter Audrey (21) and son Jason (18), and live in the residential section of campus.

Less

Stanford Profile

Jonathan Levav, PhD

Jonathan Levav is a professor of marketing at Stanford Graduate School of Business.

His research is aimed at understanding consumer’s judgments and choices by using tools from experimental psychology and behavioral economics. In particular, he studies the contextual factors that influence people’s choices and judgments. His research is both basic and applied — from probability judgment to product customization decisions.

Jonathan received his PhD in marketing from the Fuqua School of Business, Duke University, and his AB in public and international affairs from Princeton University. He is the winner of the Hillel Einhorn Young Investigator Award, awarded biennially by the Society for Judgment and Decision-Making. Prior to joining Stanford he was a member of the faculty at the Columbia Business School.

Less

Stanford Profile

John Lord, PhD

John Lord is a Lecturer for Stanford in Management Science and Engineering.

Less

Kate Rosenbluth, PhD

Kate Rosenbluth is a Founder, Member of the Board of Directors, and Chief Scientific Officer at Cala Health.

She has previously served as Chief Executive Officer and raised three rounds of financing totaling over $80M. She is an engineer and neuroscientist who previously worked on cutting edge neurotherapies at Stanford Biodesign, UCSF Neurosurgery, Brainlab, Autonomic Technologies and Genentech.

Less

Stanford Profile

Kevin Schulman, MD, MBA

Dr. Schulman was appointed as Professor of Medicine, Associate Chair of Business Development and Strategy

in the Department of Medicine, Director of Industry Partnerships and Education for the Clinical Excellence Research Center (CERC) at the Stanford University School of Medicine, and, by courtesy, Professor of Economics at Stanford’s Graduate School of Business. He is the Director of Stanford’s master’s degree program, the Master of Science in Clinical Informatics Management.

Dr. Schulman’s research interests include organizational innovation in health care, health care policy and health economics. With over 300 original articles, over 100 review articles/commentaries, and over 40 case studies/book chapters, Kevin Schulman has had a broad impact on health policy (h-index = 77). His peer-reviewed articles have appeared in the New England Journal of Medicine, JAMA, and Annals of Internal Medicine. He is a member of the editorial/advisory boards of the American Heart Journal, Health Policy, Management and Innovation (www.HMPI.Org), and Senior Associate Editor of Health Services Research.

Prior to coming to Stanford, Dr. Schulman served as a Professor of Medicine at Duke University, directed the Health Sector Management Program at Duke’s Fuqua School of Business for a dozen years, created and directed the Duke University Master of Management in Clinical Informatics Program, and served as a Visiting Professor and Visiting Scholar at Harvard Business School.

He is an elected member of ASCI and AAP. He is a graduate of Dartmouth College, the New York University School of Medicine, and The Wharton Health Care Management Program.

Less

Stanford Profile

Kristin Sainani, PhD

Kristin Sainani (née Cobb) is an associate professor at Stanford University.

She teaches statistics and writing; works on statistical projects in sports medicine; and writes about health, science, and statistics for a range of audiences. She authored the health column Body News for Allure magazine for a decade. She is also the statistical editor for the journal Physical Medicine & Rehabilitation; and she authors a statistics column, Statistically Speaking, for this journal.

Less

Stanford Profile

Linda Hoff, MBA

Linda Hoff, CFO of Stanford Health Care since 2017, has over 30 years of healthcare experience

in a variety of executive roles. Prior to joining Stanford Health Care, Ms. Hoff was the Senior Vice President and Chief Financial Officer of Legacy Health, the largest hospital system in Oregon. She has held roles as Senior Executive Vice President and Chief Financial Officer of Meriter Health Services, and President & CEO of Physicians Plus Insurance Company.

Less

Stanford Profile

Mark Musen, MD, PhD

Dr. Musen is Professor of Biomedical Informatics at Stanford University,

where he is Director of the Stanford Center for Biomedical Informatics Research. Dr. Musen conducts research related to open science, data stewardship, intelligent systems, and biomedical decision support. His group developed Protégé, the world’s most widely used technology for building and managing terminologies and ontologies. He is principal investigator of the National Center for Biomedical Ontology, one of the original National Centers for Biomedical Computing created by the U.S. National Institutes of Heath (NIH). He is principal investigator of the Center for Expanded Data Annotation and Retrieval (CEDAR). CEDAR is a center of excellence supported by the NIH Big Data to Knowledge Initiative, with the goal of developing new technology to ease the authoring and management of biomedical experimental metadata. Dr. Musen chaired the Health Informatics and Modeling Topic Advisory Group for the World Health Organization’s revision of the International Classification of Diseases (ICD-11) and he currently directs the WHO Collaborating Center for Classification, Terminology, and Standards at Stanford University.

Early in his career, Dr. Musen received the Young Investigator Award for Research in Medical Knowledge Systems from the American Association of Medical Systems and Informatics and a Young Investigator Award from the National Science Foundation. In 2006, he was recipient of the Donald A. B. Lindberg Award for Innovation in Informatics from the American Medical Informatics Association. He has been elected to the American College of Medical Informatics, the Association of American Physicians, the International Academy of Health Sciences Informatics, and the National Academy of Medicine. He is founding co-editor-in-chief of the journal Applied Ontology.

Less

Stanford Profile

Nigam H. Shah, MBBS, PhD

Dr. Nigam Shah is Professor of Medicine (Biomedical Informatics) at Stanford University,

Less

Stanford Profile

Regina Nuzzo, Ph.D

Dr. Regina Nuzzo is a freelance science writer and professor in Washington, DC.

After studying engineering as an undergraduate she earned her PhD in Statistics from Stanford University. Currently she’s teaching statistics in American Sign Language at Gallaudet University, the world’s only liberal arts college for deaf and hard-of-hearing students.

Dr. Nuzzo is also a graduate of Science Communication program at the University of California-Santa Cruz. Her science journalism specialties center around data, probability, statistics, and the research process. Her work has appeared in Nature, Los Angeles Times, New York Times, Reader’s Digest, New Scientist, and Scientific American, among others. You can read some of her writing here.

Dr. Nuzzo has been invited to speak to a variety of audiences about her work, such as why we just can’t understand p-values, how our brain can fool us during data analysis, what happens when people abuse and misuse statistics, and tips and tricks for communicating anything with numbers and statistics. You can read more about some of her talks here.

Less

Dr. Nuzzo's Website

Sara Singer, MBA, Ph.D

Dr. Singer is a faculty affiliate of Stanford’s Freeman Spogli Institute for International Studies,

Less

Stanford Profile

Tip Kim, MBA

Strategist to Stanford Health Care (SHC), a principal liaison for SHC to the broader health care market in

the Bay Area and beyond. Tip Kim is the CMO and principal leader within the Stanford Health Care enterprise with responsibility to analyze SHC's strategic and competitive positioning, to analyze options and to recommend timely actions to the Chief Executive Officer, clinical leadership, and the Board of Directors.

Less

Mhy-Lanie Adduru , MD

Mhy-Lanie Adduru is the co-CEO for Predictiv Middle East and the interim Chief Medical Officer for

Predictiv US. She is passionate on innovation at the intersection of human-centered and AI-powered medicine. Inspired by her medical training to push for a patient-centered healthcare, Mhy-Lanie and her team are bringing genomics medicine and precision medicine at the forefront of care. Prior to joining Predictiv, she led a clinical investigation on the genomics of multidrug resistant organisms impacting women's health.

Mhy-Lanie holds an M.D. from the University of Queensland. She also completed her Master's studies in Biotechnology (Bioinformatics) from Johns Hopkins University and holds a B.A. in Anthropology from the University of California at Berkeley.

Less

Shikha Anand, MD

Dr. Anand has 20 years of experience developing innovations and systems that improve health.

Her leadership experience includes public health, research, consumer health technology, and clinical informatics. A practicing physician, Dr. Anand is board-certified in Clinical Informatics from the American Board of Preventive Medicine and Pediatrics from the American Board of Pediatrics. She has previously
led health innovation, equity, quality, and informatics initiatives at Withings (Global Chief Medical Officer), Well (Chief Medical Officer), Aetna/ CVS (Chief Medical Officer, Consumer Health Products), Walmart (National Medical Director), and a series of nonprofits and federally qualified health centers.
She serves as a guest lecturer, startup mentor, and expert-in residence at Harvard School of Public Health and the Harvard Innovation Lab. As an expert in diversity, equity, and inclusion whose clinical practice serves under resourced families, she brings a unique perspective on how data and technology can be
used to empower and improve the health of diverse populations at scale.

Shikha is a proven leader in scaling new technologies into the health care ecosystem and driving innovation and quality to improve the patient/ consumer experience at community, state, national, and international levels. She has led the public health, equity, and clinical strategy in large and small for-profit and non-profit settings, including development and launch of products, health metrics, go-to market and regulatory strategy, and solutions for medical professional and consumer audiences. Her expertise includes clinical research, informatics, quality improvement, health systems, public health, strategic
planning, analytics and data science (including guiding machine learning and artificial intelligence models), organizational development, and health technology. She is passionate about ensuring that the content, products, and solutions created under her purview are accessible, scalable, and relevant to all
audiences, regardless of social or health circumstances.

Less

Oke Anakwenze, MD, MBA

Dr. Anakwenze is an Associate professor of Orthopedic surgery and head of shoulder surgery at

Duke University. He completed his medical education at the world renowned, Mayo Clinic College of Medicine. He attended the University of Pennsylvania for his orthopedic surgery training before spending an additional year at Columbia University, completing a shoulder and elbow fellowship. With an interest in leadership and entrepreneurship, he obtained an MBA from UCLA through their executive program. Prior to his role at Duke, he was the founder and CEO of Olympus Orthopedics and Advanced Surgery Center of San Diego, a successful orthopedic practice and outpatient joint replacement center respectively. Interested in entrepreneurship, he holds multiple patients in the medical device space. In addition to building a world class shoulder surgery program at Duke, Oke Anakwenze, is passionate about education and research. He has served as principal investigator for numerous research grants. In addition, he has published over 70 peer reviewed manuscripts and has given numerous scientific presentations around the country. He has been recognized for his efforts and has been the recipient of numerous research awards. Believing in paying it forward, he serves as a mentor to many students, mostly from underprivileged backgrounds. The students range from undergrads to residents in training. He recently instituted the diversity committee, dedicated to increased transparency and providing opportunities, for the American Shoulder and Elbow Society (ASES), the most significant organization for shoulder surgeon in the US and around the world.

Less

Cheryl Beal Anderson, PharmD, MBA

Cheryl Beal Anderson, PharmD MBA is an expert in pharmaceutical regulatory affairs with a

proven record as subject matter expert in US regulations, guidances, regulatory intelligence to secure drug product approval. Anderson has spent more than two decades in various pharma companies and universities, where she accumulated experience on cross-functional development teams, served spokesperson for Sponsor-FDA meetings, labeling negotiations and post-marketing compliance. She is considered a transformational leader of regulatory affairs, drug safety and quality functions and develops people to deliver innovative and exceptional results. Anderson has experience with fast-track, accelerated approval, breakthrough designation, priority review programs, orphan diseases and leading essential FDA- Sponsor meetings throughout the commercial life cycle from Pre-IND, EOP2, pre-NDA, labeling negotiation, Advertising and Promotion, and Post-Marketing Requirement. The therapeutic areas include psychiatry, neurology, oncology, cardiovascular and autoimmune, and generic products. As a corporate executive, Anderson has found solutions for complex business challenges, budget management ($20M), contributor to strategic portfolio decisions, merger & acquisition teams, due diligence assessment for company investments and helps teams generate regulatory strategies to de-risk programs throughout IND phase, NDA prosecution, commercialization, and on-market product maintenance. Anderson has a long-standing commitment to business excellence and diversity, equity, and inclusion company initiatives and employee resource groups.

As former Senior Vice President at Upsher-Smith Laboratories, LLC in Minnesota, Anderson led the Global Regulatory Affairs and Drug Safety, and Quality functions, with special emphasis on the IND/NDA programs and ANDA marketed products. She had accountability for NCEs in pre-clinical stage, FIH clinical studies in the US and UK, 505b2 NDA, and generic development, as well as executive liaison for regulatory, safety, and quality Sawai Pharmaceuticals top management in Osaka, Japan. Anderson with IT leadership gained capital to install Veeva Vault Quality Docs/ Quality Management System and Veeva Vault Regulatory Information Management System as new system to improve company-wide compliance monitoring, identifying/assessing risks and support data-driven decisions. She also set up a Culture of Quality campaign to increase employee engagement and quality in their jobs. Prior to joining Upsher, Anderson was Senior Director of Global Regulatory Affairs at Lundbeck, Inc for a global cross-functional biologic development team based in Copenhagen, Denmark in acute ischemic stroke. While at Eli Lilly & Company, Anderson was Senior Director, US Regulatory Affairs FDA Liaison group, her team generated strategies for Cardiovascular, Oncology, and Autoimmune development portfolio. She had the privilege of being a member of the FDA-Pharma Working group that developed the FDA Guidance on the Target Product Profile as a Strategic Communication Tool. Anderson was also the FDA Liaison for neurology and psychiatry development teams at Pfizer Research and Development in Ann Arbor, MI and the regulatory affairs team at Alcon Laboratories, Inc. Anderson was a faculty member from 1986-1993 at the University of Illinois at Chicago and University of Texas at Austin, Colleges of Pharmacy.

In 2013, Anderson became a member of the Center for Healthcare Innovation (CHI), Board of Directors. She is a member of the CHI Development Committee. Anderson has been a CHI symposium panel moderator and executive roundtable facilitator on increasing women and minorities in clinical trials. Anderson has merged social impact and health inequity challenges highlighted by COVID-19 as her personal interest to increase diversity and inclusion in clinical trials. Anderson was recognized as Eli Lilly Healthcare Businesswomen’s Association Rising Star, and the Center for Leadership Development Award in Business. Anderson was a 2021 Honoree of Minneapolis St. Paul Business Journal Women in Business Awards. Anderson is an advisor to the University of Texas at Austin College of Pharmacy and University of Minnesota College of Pharmacy, lecturer and students/fellows supervisor on industry rotations. She contributes to the professional community as a member of the Women’s Business Leaders in US Healthcare, Regulatory Affairs Professional Society and Drug Information Association. She is a member of The Links, Incorporated, the country’s oldest volunteer service organization of African American women leaders.

Anderson is a graduate of Texas A&M University with a BS in Biomedical Sciences. She later entered the University of Texas at Austin, College of Pharmacy where she earned both a BS and Doctor of pharmacy Degrees. Anderson went on to complete an ACPE accredited clinical pharmacy residency at the University of Texas Health Science Center at San Antonio, University of Texas at Austin, and San Antonio State Hospital, with a specialty focus in psychiatry and neurology practice. In later years, Anderson earned an MBA in pharmaceutical and healthcare marketing at St. Joseph’s University, Philadelphia, PA. Anderson finds balance and inspiration through mentoring and coaching company talent, university students/residents/fellows and high school students to encourage their decisions to choose STEM careers. In her spare time, Anderson enjoys watching select NCAA and NFL football games with her husband, being a mom to her two adult children, taking walks while listening to music and podcasts, and having new adventures through international. Anderson lives with her husband in Spring, Texas, the north of Houston, Texas.

Less

Jacob Asher, MD

Jacob Asher is a dynamic, passionate, and effective physician executive who has sought

to improve health care outcomes by leveraging extensive strategic, operational, and management experience in top tier, market leading organizations. Proven ability to develop and implement innovations in health care delivery from the patient, provider, and health plan side to drive better outcomes, lower cost, and improved consumer experience. Has served as clinical face of health plans to medical community, multi-stakeholder collaboratives, lead clinical advisor to business leadership on strategies to improve health plan performance, enhance member and provider experience through collaboration and partnerships, and reduce unwarranted variation from evidence based care. Recognized for superior oral and written communication skills, leadership of clinical and non-clinical teams, mentorship to emerging physician executives, and an ability to quickly develop credibility with physicians, clients, and matrix partners.

Specialties: innovation and healthcare policy, care management vendor partnership strategy, leveraging emerging technology to enhance physician and patient experience, value based reimbursement innovation including bundled and reference-based payments, optimizing capitated medical group performance, accountable care organization operation, driving health care strategy post ACA implementation, coordinating with industry stakeholders and regulators, creating and operationalizing evidence based medical insurance coverage policy, delivering sales presentations to new and existing corporate clients (self-funded and fully insured products), providing clinical consultations to new and existing client account teams, advising companies on best practices for improving employee health and optimizing service utilization, strong management across clinical and non-clinical teams. Regulatory compliance and plan audits, health plan board of director membership.

Less

Cynthia Barginere, DNP, RN, FACHE

Dr. Barginere Chief Operating Officer, Institute for Healthcare Improvement (IHI)

is accountable for a broad set of responsibilities across IHI; leading and supporting the infrastructure and necessary organizational elements as the company evolves and grows. Cynthia provides strategic leadership by formulating and articulating operating needs and plans to staff; by serving on the Executive Team; and by supporting the Board in its governance of key operations issues.

Prior to joining IHI, she was Chief Transformation Officer/Senior Vice President at Rush University System for Health, where she was responsible for extending the system's reach and operationalizing clinical service lines and centers across the Chicago region. Ms. Barginere joined Rush in 2011 as Chief Nursing Officer and Associate Dean for Nursing Practice, and in June 2015 she became Senior Vice President and Chief Operating Officer of Rush University Hospital. The enduring impact of her leadership can be seen in Rush’s fourth and fifth designation as a Magnet Hospital, the highest honor in nursing. From 2006 to 2011, Ms. Barginere served in a variety of positions at Baptist Medical Center South (BMCS) in Montgomery, Alabama, including five years as its COO and Chief Nursing Officer. Prior to joining BMCS, she spent 12 years at the University of Alabama Hospital in Birmingham, culminating in a four-year tenure as Associate Executive Director and Chief Nursing Officer. She received a Bachelor of Science in Nursing from the University of Alabama–Tuscaloosa, a Master of Science in Nursing Administration from the University of Alabama–Birmingham, and a Doctor of Nursing Practice from Samford University in Birmingham.

Honored as a Chicago United Business Leader of Color for 2015, Ms. Barginere has completed multiple national leadership fellowships and served as a member of numerous professional organizations, including the American Nurses Credentialing Center’s Magnet Commission and the Committee Evaluating the Future of Nursing Report at the Institute of Medicine (known today as the National Academy of Medicine). She serves on the board of the DAISY Foundation.

Less

Daphne Bascom, MD, PhD

Dr. Bascom is the Vice President of Population Health for St. Luke’s Health System in Kansas City.

Daphne partners with payors to support managed care contracts with multi-million-dollar performance-based incentive opportunities. Daphne leads a team of 3 Directors, 17 RN Care Coordinators, 3 Social Work Coordinators, 3 Outreach Specialists, 3 Health Enhancement Coordinators and 2 Community Health Workers and provides oversight for 10 health system retail Convenient Care Clinics, two Urgent Care Clinics and two Walk-In Clinics staffed by a team of >50 Advanced Practice Practitioners and Clinic Navigators.

Prior to this role, Daphne was a senior vice president and the medical director at the YMCA of Greater Kansas City. In 2018, Dr. Bascom also served as Y-USA’s Chief Health Officer. In this role, she helped local Ys define and operationalize local clinical integration strategies while leveraging existing evidence-based health programs.

Dr. Bascom was previously a Vice President and Chief Medical Officer with Cerner Corporation. Prior to re-joining Cerner, Dr. Bascom was Chief Clinical Systems Officer for the Cleveland Clinic Health System in Cleveland, Ohio.

Dr. Bascom completed her fellowship in microvascular and reconstructive surgery of the head and neck at Oregon Health Sciences University; and her medical degree, internship and residency in otolaryngology-head and neck surgery at the University of Pittsburgh Medical Center. She earned her PhD in physiological sciences at the University of Oxford, Laboratory of Physiology, in the United Kingdom.

Less

Tracy Breen, MD

Dr. Breen has served as the Chief Medical Officer at Mount Sinai West since September 2014.

In this role she oversees safety, quality and clinical care at the hospital and works closely with hospital and health system leadership across multiple service lines. Dr. Breen also manages issues related to the medical staff and frequently partners with health system leaders in risk management, legal affairs and quality. In addition to her local hospital leadership role, Dr. Breen chairs the system Med-Surg Value Analysis Sub-committee, which is part of the larger system-wide Value Analysis Steering Committee. As executive sponsor of the Mount Sinai West Diversity Council, Dr. Breen has also engaged with the Office of Diversity and Inclusion (ODI) in supporting ongoing staff training efforts aimed at identifying and reducing unconscious bias. Since the beginning of the COVID-19 pandemic, Dr. Breen has overseen all clinical response operations at Mount Sinai West with respect to developing and overseeing “surge” units, therapeutics, novel staffing strategies, and workplace safety initiatives.

Prior to her current position, Dr. Breen was Director of Diabetes Care and Chief of Endocrinology for the Northwell Health System. Previously, she served as Clinical Director for the Mount Sinai Diabetes Center for many years. In these roles, Dr. Breen worked closely with senior leadership on strategic planning, as well as developing diabetes and general endocrine services. Much of Dr. Breen’s professional focus has been on improving patient safety. The inpatient diabetes services that she implemented at both North Shore University Hospital and Long Island Jewish Hospital achieved the prestigious Joint Commission Advanced Certification in Inpatient Diabetes.

Dr. Breen earned her MD degree at the NYU School of Medicine. She remained at NYU for her internal medicine residency and served an additional year as Chief Resident. At Columbia University, Dr. Breen completed an NIH-funded research fellowship in Endocrinology, Diabetes and Metabolism, where her work focused on neuroendocrine mechanisms of energy homeostasis.

Less

Elizabeth Brill, MD, MBA, FACOG

Dr. Brill is currently detailed as the Senior Advisor to the Acting Assistant Under Secretary for

Health (AUSH) for Community Care.

She supports the Acting AUSH with oversight of contract management, payment operations and revenue operations for community care. She has also served as Chief Medical Officer for the Office of Community Care (OCC), where she assisted OCC leadership in the development and implementation of medical policies for community care as well as supporting the implementation of OCC’s utilization management, quality, and safety programs.

Dr. Brill previously served as the Chief of Staff at the Cincinnati VA Medical Center, a 1b facility with an academic affiliation with the University of Cincinnati, from 2016-2019. Dr. Brill is an Army Veteran who spent 12 years on active duty as a physician in a number of leadership roles, to include Chief of OB/GYN and Deputy Commander for Clinical Services, across assignments in South Korea, Germany and El Paso, Texas. She is a recipient of the Army Commendation Medal. Prior to the Cincinnati VAMC, Dr. Brill served as the Chief Operating Officer for Riverside Methodist Hospital in Columbus, OH. Before that, she was the Director of Surgical Services at Northwestern Memorial Hospital in Chicago, IL.

Dr. Brill completed her undergraduate studies at the Massachusetts Institute of Technology and earned her medical degree from The Pritzker School of Medicine at The University of Chicago. She was a recipient of ROTC and HPSP Army scholarships. After completing her military service, she earned an MBA from the University of Chicago Booth School of Business and worked in health care consulting with The Boston Consulting Group before returning to hospital administration.

Dr. Brill is board certified in Obstetrics and Gynecology and is a Fellow of the American College of Obstetricians and Gynecologists. She is also a certified executive coach, trained through the Hudson Institute.

Less

Emily Sarah Charlson, MD, PhD

Dr. Charlson is a specialist in oculofacial, orbital, and aesthetic plastic surgery. She is an expert in

eyelid, orbit, and tear drainage surgery including droopy eyelids and eyebrows, eyelid bags, eyelid cancer/Mohs reconstruction, eyelid malpositions, thyroid eye disease/decompression, orbital tumors or masses, and tearing due to tear drainage system problems. Dr. Charlson implements the latest medical and surgical therapies including biologics for orbital carcinoma, corneal neurotization (nerve grafting) to restore corneal sensation, and Teprotumumab for thyroid eye disease treatment. Cosmetically, she performs aesthetic eyelid, eyebrow and midface surgery, as well as injectable fillers/botox and skin resurfacing for full facial rejuvenation. Using the latest minimally invasive techniques, she strives to balance eye function and aesthetics with patient-centered customized approaches.

Dr. Charlson graduated from The University of Pennsylvania after a 7-year dual degree MD-PhD medical scientist training program. Her PhD work centered on genomics, deep-sequencing, and bioinformatics with the Human Microbiome Project. She presented her work at numerous national and international conferences with publications in Nature Biotechnology, Nature Methods and others. Her work with recognized with the University of Pennsylvania Institute for Translational Medicine & Therapeutics Prize for Clinical Translational Research and Jeffery W. Berger Ophthalmology Research Award, among others.

Less

Laura Clapper, MD

Dr. Clapper is the Chief Operating Officer and Chief Medical Officer of FemTec Health, Inc.. Previously,

she was the CMO for Cigna (Fortune Top 20) in Southern California, providing leadership to improve affordability, quality and patient experience. Prior to joining Cigna, Dr. Clapper was the Regional Vice President for Anthem Blue Cross for Clinical Strategy in National Accounts and Chief Medical Officer of Vivity, its joint venture with 7 health systems in Los Angeles. Previously she was Chief Medical Officer for OneHealth, health technology company focused on improving Behavior Health and chronic medical conditions through a mobile first, trained peer facilitators and integration with care managers.

Dr. Clapper also served as the Senior Medical Director of Aetna National Accounts in the West Region as well as at Health Net where she worked with employers and public sector business for 2.4 million members. Prior to Heath Net, Dr. Clapper was a pediatrician with Scripps Health and the US Navy, serving in a variety of leadership roles. She has also supported numerous venture-backed companies advisory and management roles. Dr. Clapper has taught at Stanford University on topics related to healthcare technology, services and innovation and also holds academic appointment with the University of California, San Diego. Dr. Clapper completed her residency training in pediatrics at National Naval Medical Center Bethesda and is a Fellow of the American Association for Physician Leadership. She received her medical degree from the Uniformed Services University of Health Sciences and her undergraduate degree from Stanford University. She also holds a master's degree of Public Policy Analysis (Health Economics) from Claremont Graduate University and was a CORO Foundation Fellow and a White House Fellowship Finalist.

Less

Adi Diner, PhD

Dr. Diner is the CEO and co-founder of iFocus health. iFocus Health is a digital health startup developing

the first truly objective measurement of ADHD treatment efficacy.

Dr. Diner has a Ph.D. in Physics from The Weizmann Institute of Science. Following the conclusion of her post-doctoral work, Dr. Diner joined the team at Elbit System as a solid-state laser physicist and team leader and went on to work at Spectra-Physics as a Senior Technical Product and Project Manager. Following this chapter, she worked for Gener8 as the director of Program Management. Since then, she has been working as consultant in the biotech and medical device space, transferring products from concept to profitable products.

Less

Alex Ding, MD, MBA

Dr. Ding is an executive in residence in the Office of Health Affairs and Advocacy at Humana,

where he focuses on special strategic projects, including in areas of value-based care, population health management, social determinants of health, and advocacy for physicians and patients.

He is a practicing physician, currently teaching and providing clinical care as faculty at the University of Louisville. Alex is a board-certified diagnostic and interventional radiologist. He was previously a managing partner at California Advanced Imaging, and also served as the Chief of Radiology and Medical Director of Imaging at Sutter Health Mills Peninsula Medical Center and on faculty at UCSF. He was trustee of the American Medical Association, during the early implementation days of the Affordable Care Act, and currently serves as the Chair-elect of the AMA's Council on Science and Public Health, during the COVID pandemic.

He has been an adviser to multiple technology companies including: Google, Eko, and Doximity, and previously served as the Chief Medical Officer at VideoMedicine, a telemedicine technology company. Alex completed a BA in Economics and MS in Public Health at UC Berkeley, his MD from UCSF, his medical internship at a Stanford-affiliated hospital, his residency and fellowship at the Massachusetts General Hospital and Harvard Medical School, and holds an MBA in finance from UPenn's Wharton School.

Less

Sri Donepudi, MD, MMM,FAAFP

Since 2018, Sri has been serving Stormont Vail Health in Topeka KS in her capacity as Senior Vice President

and Chief Medical Quality Officer. She is board certified in Family Medicine and Clinical Informatics and began her career at Stormont (an integrated multi-specialty health system) as a family physician and clinical informatics leader in 2007, leading implementation of a new EMR across a 13 county footprint and 26 clinic sites and establishing an integrated health record with the 586 licensed bed hospital. She went on to serve as Associate Chief Medical Information Officer for Christiana Care in Delaware for a couple years, supporting the transition of their ambulatory EMR before returning to Stormont in her current capacity. She has a passion for change management, strategic planning and communications and is recognized for her ability to build consensus and engagement while operationalizing strategic initiatives. She has cultivated expertise in cross-functional, interdisciplinary communication and shareholder engagement, achieving standardization, continuous performance and process improvement, and delivering greater efficiencies with superior outcomes. An advocate for leveraging technology to advance purpose and reach, she sees informatics as a bridge and adjunct to creative redesign of healthcare delivery to better serve both clinicians and patients.

Less

Tania Elliott, MD

Dr Elliott is an expert in telemedicine and digital health, leveraging connected care technologies

to bring care to patients, wherever they are. Passionate about the quadruple aim, she creates solutions to improve quality, efficiencies, access, and patient and care team experiences. She has a wealth of experience and unique expertise in driving strategy, operational excellence, and quality across a range of healthcare sectors, including health plan, health system, startup, and employer. She is currently Chief Medical Officer of Virtual Care at Ascension, advancing adoption of virtual visits and remote patient monitoring across the care continuum and developing new care delivery models for chronic disease management, behavioral health, and hospital-level care at home. Ascension is one of the largest healthcare systems in the country with 150,000 associates and 40,000 providers at 2600 sites, including 150 hospitals in 20 states. She served as a clinical solutions medical director at Aetna, a CVS company, supporting development of digital engagement and behavior change strategies for women's health, virtual primary care, and cardiovascular disease, and as Chief Medical Officer of EHE, a 106-year-old nationwide preventive health and wellness company, where she developed a novel, evidence-based preventive care model that leveraged a suite of digital engagement solutions to keep employees productive, healthy, and up-to-date on age and risk-factor based preventive screenings. Dual board certified in Internal Medicine and Allergy and Clinical Immunology, Dr. Elliott embraced telemedicine first as a physician, and then as Medical Director of Doctor on Demand, developing the Nation's first fully employed, nationwide "Virtualist" physician workforce.

Tania currently chairs the Telemedicine and Technology Taskforce for The American College of Allergy, Asthma and Immunology and the American Academy of Allergy Asthma and Immunology and has published multiple peer reviewed journal articles on direct to consumer healthcare delivery and implementation of virtual care into clinical practice. She serves regularly as a healthcare broadcast media expert regularly featured on top shows including Good Morning America, Rachael Ray, Dr. Oz, Dr. Phil, The Doctors, and CBS This Morning.

Less

Shamiram R. Feinglass, MD, MPH

Dr. Feinglass is the Chief Medical Officer for Danaher DxLS and Beckman Coulter. Driving inclusion

and diversity in every environment in which she works or leads, Dr. Feinglass leads Global Medical Affairs, Reimbursement, & Health Policy for Life Sciences and Diagnostics and is responsible for leading the global pandemic response plan across the company, inclusive of all 70,000 associates. Often working with global leaders and regulators, Dr. Feinglass formerly led Global Medical and Regulatory Affairs at Zimmer, Inc., has served as a Medical Officer at the Centers for Medicare and Medicaid Services, in the Coverage and Analysis Group, and as a Commander with the U.S. Public Health Service. She has also been clinical faculty at several health sciences universities and her work has been widely published. A graduate of Smith College, Dr. Feinglass earned her Doctor of Medicine and Master of Public Health from the Emory Schools of Medicine and Public Health. She completed an Internal Medicine Residency at Oregon Health Sciences University, a Preventive Medicine Residency at Emory School of Medicine, and the Robert Wood Johnson Clinical Scholars Program at the University of Washington. A sought-after speaker and expert in international medical device and diagnostics policy, Dr. Feinglass has served on a variety of panels for the FDA, FasterCures, The Brookings Institute, Pew Charitable Trusts, Oxford University, and international registry groups. A mother of two, she is currently a BMX state champion and was a member of the USA BMX World Championship Team. Dr. Feinglass was an Aspen Health Innovators Fellow and is a member of the Aspen Global Leadership Network.

Less

Linda Genen, MD, MPH

Dr. Genen is an experienced physician executive who has spent her career focused on improving the lives

of women and children.

In her current role as Chief Medical Officer at ProgenyHealth, she oversees the clinical operation and is responsible for the advancement of products supporting women and children. She provides leadership in areas of Claims & Clinical Operations, Policy Development, Quality Management, Information Technology & Infrastructure, Clinical Configuration, Data Analytics, and Client Implementations. She serves as a Board Member for Hera Women’s Health and consults on various healthcare enterprises. She has facilitated initiatives to help prevent maternal and infant mortality and address racial disparities in healthcare. She is passionately interested in technology and machine learning applications that will help ensure timely care and improve outcomes. In addition to her full-time role, she is a Distinguished Mentor at Stanford Medical School in the Master of Science in Clinical Informatics Management (MCiM) program.

Her most recent role was as a Senior Research Fellow for United Health Group Research and Development helping to advance innovations in healthcare. Prior to moving over to R&D, she was the Chief Medical Officer for Women’s Health at Optum servicing Fertility, Maternity and Neonatal programs. She has shaped the operations of these programs directing teams, developing reporting, advising analytics and supporting sales. She is known for her innovative approach in designing population health programs for both Commercial and Medicaid markets and received the Innovation Award in 2020 from UnitedHealth Group. Previous roles involved National Medical Director at ParadigmHealth and Alere before joining Optum.

Less

Alexandra Gonçalves, MD, MMSc, PhD

Dr. Gonçalves is Chief Medical Officer, Strategy & Partnerships for Philips.

Dr. Goncalves is a cardiologist with a business acumen and an extensive record of multi-disciplinary collaborations spanning the globe, as educator, author, editor, clinical researcher and thought leader.

Less

Elaine Goodman, MD, MBA

Dr. Goodman is a practicing internal medicine physician who has worked in health technology

across many settings including academic centers, health IT start-ups, venture capital investing, pharmaceutical companies, payors, and providers.

She is passionate about democratizing access to technology for all patients and addressing technology’s contribution to clinician burnout. She previously worked as the Associate Chief Medical Officer for the healthcare IT start-up Wellframe, where she helped lead the company from the seed stage through Series C funding. For the last year she has focused on the COVID pandemic and serves as the director of the Massachusetts General Hospital (MGH) respiratory illness/COVID clinic. She is also the Director of Urgent Care and After Hours Innovation at for the MGH Division of Primary Care, where she is designing new, post-COVID urgent care models incorporating virtual care, new triage tools within the EHR, and access to services such as at-home urgent care and remote patient monitoring to prevent Emergency Department visits. Dr. Goodman is also the Mass General Brigham Venture Fellow where she is a member of the AI and Digital Innovation Fund leadership team. This fund invests in early-stage companies from outside Mass General Brigham and facilitates strategic collaborations between these start-ups and the health system. She continues to advise many start-ups as an expert mentor for the Harvard Innovation Lab.

Less

Ben Green, MD

Dr. Green is a Principal at Amazon. Formerly, Dr. Green was the Regional Medical Director at Landmark

Health. Landmark's patient-centered, comprehensive, house call model is designed for those in our communities that truly need it the most, whenever they need it and wherever they reside. Dr. Green is passionate about innovating health care delivery and helping Landmark to transform health care by dramatically improving the quality of life in our communities. He is perpetually interested in solutions in which modern technology can augment traditional care.

Prior to Landmark, Dr. Green spent the previous 8 years at Carena, Inc. of Seattle where he was the Medical Director for Clinical Innovation. While there he helped to usher in Carena's transition to from in-person house calls to virtual health care and telemedicine, and built a team of medical professionals focused on this novel field of medicine. He was directly involved in building the clinical software and operational infrastructure to deliver safe, high quality, and evidence-based urgent and primary care telemedicine.

Dr. Green holds a BA from Harvard University in Biological Anthropology, an MD degree from the UMDNJ-Robert Wood Johnson Medical School and completed his Family Medicine residency at the University of Pennsylvania.

Less

Ranya Habash, MD

Dr. Habash is Medical Director of Technology Innovation for Bascom Palmer Eye Institute and

was recently appointed to the FDA’s Digital Health Network of Experts. She was named to the Ophthalmologist Power List, first recognizing the top 50 stars in the world "who will lead ophthalmology over the next few decades and shape its future" and most recently as one of the “most influential” female ophthalmologists in the world.

Dr. Habash is also Chief Medical Officer of Everbridge and Co-Founder of HipaaChat. She was listed by Becker's Hospital Review as a Top Healthcare Entrepreneur to Know. As a publicly-traded global leader in critical communications, Everbridge integrated HipaaChat’s secure messaging and telemedicine platform within its software suite, serving over 1500 hospitals and health systems. As Chief Medical Officer she provides strategic clinical insight for Everbridge’s business development, sales, and product teams, while collaborating with companies like Apple, Amazon, and Verizon to modernize communication for health systems. This includes HIPAA-compliant communication between doctors, nurses, and staff, automated code alerts, IoT monitoring of medical devices, mobile SOS safety software, and care coordination between hospitals, ambulances, and emergency services on a city-wide and state-wide scale. At the start of the COVID pandemic, Habash was identified to lead telehealth implementation for the medical community. Her training sessions and materials were embraced internationally and her work was cited in Senate Committee hearings for telehealth expansion in all medical specialties.

Combining her unique clinical, tech, and product backgrounds, Habash joined Microsoft’s healthcare team to lead a global machine learning project between Microsoft and Bascom Palmer, delivering a multi-disease retinal algorithm to automate diagnosis and treatment of eye conditions. As program manager, she worked to build a global collaborative network for data sharing. Using her expertise in clinical applications and the business of medicine, her latest research focuses on brain-machine interface technology for the diagnosis and treatment of multiple ophthalmic and neurologic conditions.

Less

Florencia Halpern, MD, MMS

Dr. Halpern is an endocrinologist with a clinical, teaching and research focus on obesity medicine.

After more than a decade in academia, in 2019 I transitioned to a leadership role in a start-up company, which delivers an evidence-based, multi-disciplinary medical weight loss intervention (provided by highly specialized board certified physicians and dietitians) entirely through an app. She is delighted to be invited to be a Stanford mentor, and happy to help Stanford students with anything related to careers in healthcare.

Less

Chandresh Harjivan, MD, MBA

Chandresh (Chan) Harjivan is the Acting Chief Executive Officer, Chief Operating Officer and

Co-Founder of SaponiQx, funded by AgenusBio and GingkoBioworks, and has over 15 years of experience in management consulting.

Dr. Harjivan has dedicated his career to improving public health, first within the pharmaceutical and health care industries, and then in the public sector. His career has led him to work at powerful companies such as PwC and Boston Consulting Group, where he led public health consulting. He has advised companies, NGOs, and governments on crucial issues, including understanding the epidemiology of existing and emerging diseases, the development and delivery of technologies against those diseases—whether new diagnostics, drugs, vaccines, or digital tools—as well as on advising where to make healthcare investments.

Dr. Harjivan graduated from Massachusetts College of Pharmacy and Health Sciences in 1995 with a Bachelor of Science in Pharmacy, and received a Master of Public Health from Johns Hopkins University, a Master of Business Administration from Oxford University, and a Doctor of Pharmacy from the University of Maryland.

Dr. Harjivan holds an active Top Secret clearance, Six Sigma Black Belt, and is a licensed Pharmacist.

Less

Alisahah Jackson, MD

A musician, a physician, a mother, a volunteer, and a leader are just a few words to describe

Dr. Alisahah Jackson. Above all, she is highly passionate about health equity, advocating that everyone should have the ability to achieve great health, no matter what they look like, how much money they make, or where they come from. Since serving the underserved had always been a priority, she completed her residency in Family Medicine at Carolinas Medical Center, where she was part of the Urban Track program. During that time, she received the Bryant L. Galusha Intern of the Year Award and served as Co-Chief Resident her final year. Since completing medical school, Dr. Jackson has held multiple leadership roles including Medical Director of a rural health clinic in SC, Residency Program Director, and Chair of the Department of Family Medicine. She was named the first ever Chief Community Impact Officer at Atrium Health where she created the first Community Health Department, establishing the first Health Equity and Social Determinants of Health strategies. Most recently, Dr. Jackson joined CommonSpirit Health as its first System Vice President of Population Health Innovation and Policy, with responsibilities for strategy development regarding vulnerable populations, health equity, and innovative care delivery models.

Less

Lynn Jeffers, MD, MBA

Dr. Jeffers has focused her clinical practice on aesthetic and reconstructive breast surgery, as well

as noninvasive and minimally-invasive rejuvenation. However, she has had a long-standing interest in innovation and technology. She has lectured on Big Data, EHR’s, disruptive technology in healthcare, written a textbook chapter on Digital Health in Plastic Surgery, beta-tested for companies, and is involved in a citywide Start-Up Weekend. More traditionally, she participated in the Mentor Adjunct Study, the Mentor Post Approval Study, the Sientra Silicone Gel Large volume study, the Breast Reconstruction and Augmentation with the BRAVA enhanced autologous Fat Micro Grafting, and the ASPS SPAR Multicenter Trial. Until recently, she served as the Medical Monitor for the US Post Approval Study for Sientra.

Leadership, Health Policy, and Advocacy:

Dr. Jeffers has been active in organized medicine and leadership development at the local, state, and national level, serving on the Board of two national specialty societies and one state specialty society. She served as the Preident of the American Society of Plastic Surgeons from 2019-2021 during the COVID-19 crisis. As Chair of the Leadership Development Committee, she was instrumental in the creation of a national Leadership Development Program. As one of 11 members on the AMA Council on Medical Service, she helps to craft national policy proposals and reports regarding socioeconomic issues in medicine.

Dr. Jeffers's leadership has been recognized by her receipt of national, regional, and local awards for leadership, innovation, health policy and advocacy, patient care, and research. She has been quoted in Forbes, Fortune, NYTimes, LA Times, and other news media.

Less

Gerard Jenkins, MD, MA

Dr. Jenkins is a healthcare professional with a unique expertise in the disciplines of medicine, business,

science, and technology. He has worked in healthcare for almost 20 years while earning numerous accolades and he has been a physician for over 10 years. He actively practices Internal Medicine as a Hospitalist Physician and he is also the Chief Medical Officer of a Federally Qualified Health Center. Given his diverse knowledge, Dr. Jenkins is often sought for a variety of reasons including clinical case review, healthcare technology application development, biomedical-biopharmaceutical investment analysis, and healthcare market perspective. He has worked with numerous organizations ranging from early-stage venture companies to publically traded corporations to academic institutions.

Dr. Jenkins completed his Bachelor of Science degree from the University of Michigan during which time he participated in basic science research within Biochemistry & Immunology. Afterwards he moved to New York and graduated from Columbia University with two degrees, a Master of Art in Biotechnology and a Master of Art in Biomedical Informatics. While attending graduate school, he contributed to a laboratory dedicated to Genetics & Development before transitioning to business development and conducting licensing deals for a venture company. He then attended Vanderbilt University and completed his Medical Doctorate degree while also leading multiple projects in the departments of Biomedical Informatics and Critical Care Medicine. Following medical school, he pursued Post-Doctorate training in Clinical Pharmacogenomics at the University of California San Francisco where he conducted novel genomics research with significant clinical applications towards diabetes mellitus.

Less

Nerissa Kreher, MD, MBA

Dr. Kreher is an innovative and versatile industry physician, board certified in Pediatric Endocrinology,

with a combination of academic, clinical research and biotechnology industry experience. Biotech/pharma experience includes both Medical Affairs and Clinical Development. Proven ability to build and expand Medical Affairs teams, work collaboratively with multi-disciplinary functions and accomplish objectives. Clear understanding and ability to execute medical strategy with firm grasp of commercial aspects of business. Outstanding oral and written presentation skills with ability to relay information to audiences of varying levels of expertise.

Less

Priti Lakhani , MD

Priti Lakhani is a board-certified podiatrist with a passion for safety and patient experience.

Her background is rich and varied. She practiced as a Surgical Podiatrist for 15 years, seeing patients and advocating for system improvements to decrease variability. She obtained her Master’s in Healthcare Management, graduating Magna Cum Laude from the Harvard School of Public Health. Working for Cerner as a Physician Executive, she assisted her clients through implementation, physician engagement, and population health. She led the Physician Leadership workshop teaching change management and governance. As a Director at Cerner, she was a formative member of the Patient Safety Council.

She guided Microclinic Technologies, as an Executive Vice President overseeing operations, to decrease maternal fetal mortality in East Africa. Serving as a Health Equity Officer at a rural Kansas hospital to meet the needs of a multi-cultural population at a beef packing plant showed her firsthand the importance of patient experience. Running Polio Project camps in India added to her passion to provide access to public health and prevention. As a medical advisor to a startup company, she oversaw development of workflows, education, and access. She served as Chief Medical Information Officer in Philadelphia. As Director of Quality, Safety and Value in the Office of Electronic Health Record Modernization, she oversaw safety for the largest healthcare enterprise in the US, the Veteran’s Health Administration during their initial operating capacity site. Currently, she serves as a Principal Health Systems Specialist at MITRE, a federally funded research and development center (FFRDC).

Less

Lisa Soleymani Lehmann, MD, PhD, MSc

Dr. Lehmann is a primary care physician and bioethicist.

She currently serves as Head of Bioethics and Trust at Google and is Associate Professor of Medicine (part time) at Harvard Medical School (HMS) and Associate Professor of Health Policy and Management (part time) at the Harvard T. H. Chan School of Public Health. From 2017-2020 Lisa was Chief Medical Officer for the VA New England Healthcare System which is a multi-state integrated healthcare system comprised of 8 medical centers and 41 community-based outpatient clinics that serves over 260,000 Veterans. Prior to serving VA New England, Lisa was Executive Director of the VA National Center for Ethics in Health Care, Director of Bioethics at Brigham and Women’s Hospital, and a practicing primary care physician and health services researcher at Brigham and Women’s Hospital.

Less

Lotus Mallbri, MD, PhD, MBA

Dr. Mallbris was named to her current position of Vice President, Immunology Development,

Lilly Bio-Medicines Business Unit, in July 2017. Lotus joined Lilly in 2015 and has held leadership positions in development functions. Her most recent role was Global Brand Development Leader – Immunology in Lilly’s Bio-Medicines Business Unit, overseeing a multifunctional team to augment the Taltz® development program and launch readiness.

Prior to joining Lilly, she held several academic and leadership roles at Karolinska Institute and Pfizer.

Lotus received her medical degree from Karolinska Institute in Stockholm, Sweden, and obtained a Ph.D. from Department of Medicine at Karolinska Institute, Sweden. She continues to be an active member of several external immunology research advisory committees, bridging the external state-of-the-art research with Lilly. Lotus is the recipient of the 2021 Health Industry Visionary Award from the Society for Women’s Health Research (SWHR). The SWHR recognized the commitment to improving the lives of millions of people with autoimmune diseases by furthering innovation in health care, solving problems for patients and for advancing a diverse and inclusive workforce in the pharmaceutical industry.

Lotus is a mother of two girls. She enjoys watercolor painting, yoga and spending time with her family.

Less

Elizabeth Malko, MD

Dr. Malko is Florida Blue’s Vice President & Chief Medical Officer for Medicare Solutions.

In this role, Dr. Malko and her team are responsible for delivering innovative and successful Government Pharmacy Programs, Special Medicare and Medicaid Needs Plans and Medicare Quality and STARS Programs. Additionally, she and her team ensure members receive evidence based medicine and coordinated care and are responsible for creating and managing provider engagement in population health.

With more than 20 years of managed care experience, Dr. Malko has extensive management experience in the for-profit and not-for-profit payor settings, including leadership of engineers, physicians, pharmacists, nurses, administrative, and managed care staff. Dr. Malko was formerly the Executive Vice President/ Chief Medical Officer at MVP Health Care. And as Executive VP for Clinical Transformation and Operations at Evolent Health in Arlington, Virginia, she led a staff of more than 350 associates in clinical transformation and innovation, clinical operations, quality, and clinical strategy and relationships.

Previously, Dr. Malko served as the Executive Vice President & Chief Medical Officer for Fallon Community Health Plan in Worcester, Massachusetts, Regional Medical Director for WellPoint Inc.’s state-sponsored business, and Lead Medical Director for Anthem BCBS in New Hampshire and Connecticut.

Malko received a B.S. in Biology, and Master’s degree in Environmental Engineering from Rensselaer Polytechnic Institute. Her M.D. was awarded by the University of Connecticut, she was Board Certified in Family Practice, and is an active Fellow of the American Academy of Family Practice.

Less

Arndres Mason

In her current role as Vice President of Operations at Avalon, the world’s first lab insight’s company,

Arndres provides leadership within the Claims & Provider Network Operations, Utilization Management, Client Implementations and Operational Excellence areas. She has held innovative leadership roles in the healthcare technology sector, focusing on Commercial, Medicare, and Medicaid health insurance. She uses her extensive background in financial services, technology, and consulting to bring disruptive, cutting-edge ideas to deliver seamless healthcare systems and operations. She is passionate about integrating innovation and automation into the operations space.

Previously, she was the Director of Medicare business process operations for a top 10 global IT services provider organization. She specialized in integrated service delivery, bringing value to clients, and increasing account growth through process improvement and automation. One of her team's achievements was developing a multi-platform automation tool to integrate multiple government and health plan systems. Under her leadership, she has saved health plans millions in reconciliation initiatives.

She provides consultative Medicare expertise in planning enterprise and strategic projects. Her unique ability to connect with people and a passion for developing strong partnerships translate to her expertise in building culturally dynamic high-performing teams.

She holds a Master’s of Healthcare Administration from Purdue University Global and a Bachelor of Science in Financial Management from Johnson & Wales University. She is a certificated Project Manager, Business Analyst (Bryant University), Lean Six Sigma Black Belt, and Agile and Scrum practitioner.

Less

Lena Mass-Cresnik, PhD

Dr. Mass-Cresnik is the Chief Data Officer at Moelis & Company, where she oversees the Firm’s

Data Analytics efforts.

Dr. Mass-Cresnik has more than 18 years of experience creating innovative, cross-functional technology solutions — covering AI/ML, data science, investments, FinTech, R&D, cloud, and mobility, among others — across the financial services industry. Previously, she was the Head of Technology Strategy and Technology Research & Development in the Office of the CTO at Charles Schwab. Prior to that, Dr. Mass-Cresnik was at BlackRock, where she held the roles of Global Head of Innovation in Technology and Head of Innovation in Strategic Product Management focused on institutional and retail investment products. There she established a new technology engagement strategy & model focused on emergent technologies and investments, early stage start-up technologies, collaborations with Silicon Valley, product and service scalability, and evaluated their feasibility and commercial viability globally.

Dr. Mass-Cresnik holds a DPhil (PhD) from the University of Oxford in Innovation & Technology Management, where she focused on complex systems and networks. She also holds a MS from Harvard University in Policy & Management and a BA from Wellesley College in Economics. She is a member of the Federal Reserve Bank of New York’s FinTech Advisory Group and World Economic Forum’s Technology, Innovation, and Systemic Risk in Financial Services Steering Committee. Dr. Mass-Cresnik has spent several years collaborating on research around Artificial Intelligence and Machine Learning with the World Economic Forum. She is also an Advisory Board Member at Atlas Crest Investment Co. and Executive Mentor at the Stanford University School of Medicine.

Less

Cathleen McCabe, MD

Dr. McCabe serves as Chief Medical Officer at Eye Health America^™.

She is one of the foremost eye surgeons today, specializing in bladeless laser cataract surgery and LASIK at The Eye Associates in Sarasota, Florida. Dr. McCabe has performed over 45,000 cataract surgeries and more than 17,000 LASIK procedures. She has a keen interest in advancing the field of ophthalmology and has participated in numerous clinical trials, including innovations in intraocular lenses, perioperative medications, medications and devices to treat glaucoma, dry eye treatments and presbyopia correction.

Dr. McCabe continues to receive many prestigious and esteemed awards for her work in Ophthalmology, including being named a Castle Connolly Top Doctor – 2015, 2016, 2017, 2018, 2019 and 2020 for Ophthalmology. Castle Connolly also selected her for the first-ever Exceptional Women In Medicine Award for 2017, 2018, 2019 and in 2020. She was named to the OSN Premier Surgeon 300 List, and the Premier Surgeon 250 List of Leading Innovators in Premium IOL Cataract Surgery. She was also chosen a LASERVISION Top 100 LASIK Surgeon, elected President of CEDARS/ASPEN-2017, has received the American Academy Achievement Award, is the Vice President and incoming President of the Outpatient Ophthalmic Surgery Society, and serves on numerous editorial and subspecialty boards and committees. She is passionate about giving back to her local community, profession and globally and participates in charitable giving and volunteer efforts both at home and abroad. She is a board member of several charitable foundations in ophthalmology, including One World Global Health/Vision Quest, OOSS Gives, and others. Dr. McCabe received her medical degree from the Medical College of Wisconsin and received her residency training at the prestigious Bascom Palmer Eye Institute at the University of Miami’s School of Medicine. She continues to share her expertise by publishing articles and book chapters as well as lecturing at national and international ophthalmological seminars.

Less

Dana McClintock, MD

Dr. McClintock is currently the Chief Medical Officer at Alladapt Immunotherapeutics, Inc., a role

she’s held since 2018. She is also currently a member of the clinical and scientific advisory board of Vasomune Therapeutics. Prior to joining Alladapt, Dr. McClintock was Global Head of Innovation for Immunology, Infectious Disease and Ophthalmology at Genentech/Roche. Her responsibilities included accelerating use of emergent technologies and enabling novel approaches to clinical development with a focus on pediatrics. Prior to this role, Dr. McClintock, held roles of increasing responsibility at Genentech/Roche, including Global Head of Pipeline and Portfolio planning for Immunology, Infectious Disease and Ophthalmology as well as Interim Global Co-Head of Ophthalmology.

Earlier in Dr. McClintock’s pharmaceutical career, she was deeply involved in respiratory, immunology and ophthalmology clinical development activities across a range of phases, from IND-enabling work and early clinical trials through post-marketing commitments and medical affairs activities. Dr. McClintock was involved in key clinical development activities for omalizumab (Xolair) and ranibizumab (Lucentis) as well as other pipeline molecules. Prior to joining the pharmaceutical industry, Dr. McClintock’s academic research focus was in ARDS, with publications evaluating ventilator parameters as well plasma biomarkers of epithelial and endothelial cell injury. Dr. McClintock received her BA in Chemistry from Duke University and her MD from the University of Virginia School of Medicine. Dr. McClintock completed both her Internal Medicine residency and Pulmonary and Critical Care fellowship at the University of California, San Francisco.

Less

Daniel Moskovic, MD, MBA, MA

Dr. Moskovic is a Partner with McKinsey’s Healthcare Systems & Services practice and has been with the Firm for 9 years.

Daniel leads the Firm’s client service in health system external spend management and healthcare services with an emphasis on strategy and operations for supply chain intermediaries and healthcare real estate owners/operators. Daniel founded McKinsey’s Provider Performance Improvements advanced analytics team, now with 30 consultants delivering advanced analytics and expert-based consulting to McKinsey’s clients.

Daniel speaks around the world on health system operations with emphasis on the evolving healthcare supply chain and has published various articles on health system external spend management topics such as: medical equipment optimization, pharmacy and design and construction optimization.

Lead strategy agenda across medical distribution and GPO clients with an emphasis on core growth, adjacency entry and value proposition refinement.

Supported several physician management groups, clinical services players, seniors housing owner and healthcare services providers on strategy and operations effectiveness.

Less

Mary I. O’Connor, MD

Dr. O’Connor is a co-founder and Chief Medical Officer of Vori Health, a new musculoskeletal medical startup company.

She is a nationally recognized leader in health equity, chairing the Movement is Life Caucus, a multi-stakeholder coalition committed to addressing musculoskeletal health disparities since its inception in 2010.

Dr. O’Connor is a Professor Emerita of Orthopedics at Mayo Clinic and past Professor of Orthopaedics and Rehabilitation at Yale School of Medicine. She practiced at Mayo Clinic in Florida until 2015 during which time she served in many leadership roles: Enterprise-wide Medical Director of Compliance; Chair, Orthopedic Surgery Department (FL); Medical Director for Development (FL); and member of the Executive Operations Team (FL). In 2015 she became the inaugural Director of the Center for Musculoskeletal Care at Yale School of Medicine and Yale New Haven Health. In February of 2021, she joined Vori Health.

Dr. O'Connor is the Past President of numerous orthopedic professional societies. She served as Chair of the American Academy of Orthopaedic Surgery Diversity Advisory Board and Women’s Health Issues Advisory Board. Dr. O’Connor is the recipient of the Mayo Clinic Distinguished Clinician Award.

In November 2020, Dr. O’Connor’s TEDx talk, “Promoting Health – Your Secret Superpower” highlighted the Movement is Life Operation Change program and the privilege and responsibility for each individual to be a health promoter for those around them. As a featured speaker at the July 2018 New England Journal of Medicine Catalyst event, Dr. O’Connor highlighted the power of teams in addressing health disparities, “Title IX to Health Equity: The Power of Teams”.

Less

**Nnaemeka 'Emeka' Okafor, MD, MS**

Dr. Okafor serves as the Vice President, Chief Analytics and Informatics Officer for Memorial Hermann Health System (MHHS)

in Houston. He has been an informatics Physician executive with MHHS since 2014. Current duties include serving as a trusted problem-solving liaison for clinicians, health system executives, Information Technology (IT) staff, and IT vendors. He provides leadership for enterprise-wide Health Information Technology (HIT) and Electronic Health Record (EHR) planning, development, design implementation and benefit realization. He is also responsible the developing of informatics resources, expanding the MHHS virtual health footprint and maturing analytics for the Health System.

He is boarded in Emergency Medicine, Clinical Informatics and Medical Quality. He has been part of the academic faculty at the McGovern Medical School in Houston since 2007 and still practices Emergency Medicine, educating fellows, residents and medical students. He has research published on medical error reporting, diagnostic errors, patient care transitions and data visualization. He completed his medical school at University of Missouri-Columbia, and his emergency medicine residency at Boston Medical Center.

Less

Shika Pappoe, MD

Dr. Pappoe is a pioneer and a nephrologist. She has blended medicine, public health, and business

administration to give her a perspective that is unlikely to be shared by many others. She completed her undergraduate and medical degrees at Yale University, followed by her internal medicine residency and nephrology fellowship at Brigham and Women’s Hospital. During her fellowship, she returned to the classroom to add a Master of Public health degree from Harvard University. After completing her MPH, she moved to California and joined the Royalty Nephrology Medical Group. While she loved practicing community nephrology, she was eager to return to an academic setting where she could teach, participate in research and work in an innovative care setting. She therefore moved to the nephrology division of the Keck School of Medicine. She was assigned to work at Los Angeles County Hospital, one of the country’s largest safety-net hospitals, where she was able to focus her energies on providing care to underserved communities.

After working in a variety of healthcare settings and seeing both the broken parts of the system and opportunities for innovation, she decided that it was time to be part of the solution. In her pursuit to become a physician leader, she earned a business degree from Wharton’s executive MBA program. With her experience in kidney care, her mounting education in medicine, public health, and business management, and most importantly, her passion around improving the patient experience, Dr. Pappoe reentered the workforce with CareMore, a leader in value-based care. She served as the Director of Nephrology and Kidney Disease Prevention, overseeing care delivery for thousands of patients in multiple clinical programs region-wide. Dr. Pappoe’s unique collection of education and experience has proved invaluable in designing and launching Strive’s clinical model as Chief Medical Officer.

Less

Plamen Petrov, PhD

Dr. Petrov is Co-founder and Chief Technology Officer of Hydrogen Health.

Leading a team of engineers, data scientists, AI experts, and product managers developing industry leading digital health products and solutions Specialties include: Artificial Intelligence, Cognitive Computing, Chief Architect, Chief Enterprise Architect, Advanced Analytics, Enterprise Architecture, Software Architecture, Healthcare, Data Science, Operations Management, Engineering Management, Executive Management, Technology Strategy, Architecture Strategy, Analytics, Predictive Analytics, Big Data, High Availability Clustering, Wireless Communications, Software Quality, Software Testing, Business Intelligence, Data Warehousing, Modeling, Project Management, Research and Development, Service Oriented Architecture, Data Architecture

Less

Terri L. Phillips, MD

Dr. Phillips is the Chief Medical Affairs Officer for Merz Aesthetics, the largest dedicated medical aesthetics

company in the industry. She joined Merz in January 2018 as Vice President and Head of Global Medical Affairs, providing oversight to the global medical affairs function for the company’s two businesses in medical aesthetics and neurosciences.

Dr. Phillips is widely recognized for her scientific, technical and business innovation expertise and has been in the biopharmaceutical industry for more than 19 years. Before joining industry, she practiced full time in Neonatal/Perinatal medicine, serving as Medical Director for a large, multi-site practice in the Washington D.C. metropolitan area. Prior to joining Merz, Dr. Phillips was Vice President of Global Medical Affairs at Santen where she led and built the company’s first global medical affairs function. Her industry experience includes executive leadership roles at Allergan, NPS Pharmaceuticals and as a specialty consultant to emerging medical affairs organizations in numerous therapeutic areas.

Dr. Phillips holds a bachelor’s degree from Bennett College for Women and a doctor of medicine degree from Morehouse School of Medicine in Atlanta. She is dual board certified and completed her Fellowship training in Neonatal/Perinatal medicine. She is a veteran of the United States Army, Medical Corps where she was a recognized leader and the recipient of numerous awards, including the Army Commendation Medal. She has served as author of text and journal articles, is an active community volunteer serving as Chair of the American Heart Association Triangle Go Red (2020) and as a current board member of the Triangle American Heart Association. She has been recognized as one of “America’s Top Pediatricians”. She is a recipient of TBJ’s Women in Business (2020) and C-Suite (2019) awards.

Dr. Phillips is a member of Merz’s Global Leadership Team.

Less

John Pyhtila, PhD

Dr. Pyhtila is a senior executive in healthcare analytics and informatics market with proven leadership

experience in strategic planning, analytics, operations, client services, and product management. He has a results oriented approach to translate strategic direction into tangible actions for team with a focus on individual accountability and mentorship.

Less

Rebecca Ramirez, MD, MHCM

An innovator at heart, Rebecca Ramirez started Dr. Becky’s Blog, a health resource for people receiving

virtual care at home.

Dr. Ramirez is Chief Clinical Advisor at Healthcare Advisory Network providing consultative services for practices and organizations who leverage technology to provide high quality human centered care delivery.

Dr. Ramirez joined Healthcare Advisory Network in 2020 with 20+ years of clinical leadership as a health care executive and hospitalist physician. As a board-certified Internal Medicine physician, Dr. Ramirez impacts health care transformation with physician engagement, change management techniques and innovative technology selection and application.

Prior to Healthcare Advisory Network, Dr. Ramirez served as the Chief Transformation Officer for a $2B Dollar Health System where she was the strategic and operational leader for the Clinical Revenue Cycle across nine hospitals. Dr. Ramirez was responsible for integrating clinical activities with revenue cycle functionality. She used data, digital tools and process improvement techniques as part of a comprehensive approach to improve physician engagement with CDI and Case Management teams. Consistent with her track record of success, Clinical Revenue Cycle integration resulted in net revenue growth of $5M and 80% reduction in status denials in year one.

Dr. Ramirez earned a Master’s in Health Care Management at Harvard University. She serves as a distinguished mentor in Stanford University’s School of Medicine, Master of Science in Clinical Informatics Management. She is a coach in the Society of Hospital Medicine’s (SHM) Leadership Academy Capstone Course and founding member of the SHM Capstone Advisory team.

Less

Jeff Ries, MBA

Jeff Ries manages the DaVita Venture Fund on behalf of Healthbox.

Previously, he led the Intermountain Healthcare Innovation Fund where he led investments in Zebra Medical Vision, Syapse, Sera Prognostics and Collective Medical Technologies. Jeff was formerly at Oxeon Partners where he focused on building and investing in healthcare companies. He was also an investor at Sandbox Industries where he helped manage BlueCross BlueShield Venture Partners. While at Sandbox, Jeff started several tech-enabled startups and helped raise capital for Cultivian Sandbox, an agriculture-technology venture fund. He began his career at LaSalle Investment Management, a private equity firm with $50B AUM. Jeff resides in New York City and received his BA in Economics from Northwestern University and his MBA from Harvard Business School.

Less

Ruth Schleyer, MSN

Ruth Schleyer is a People-Focused, Mission-Inspired, Nursing Informatics Leader who

is a Strategic Systems Thinker and Collaborative Partner committed to realizing the power and possibilities of connecting compassionate care and innovative technologies for health and well-being.

► Transformational Leader with enterprise-level experience in design, implementation, adoption, and optimization of healthcare information systems.

► Clinical Advocate for educating the healthcare workforce about informatics-related knowledge and skills essential for informed decision-making from bedside to boardroom.

► Trusted Relationship and Team Builder who inspires, engages, and empowers interprofessional teams and learning communities in support of organizational goals.

She serves with an open heart, centered and focused on the patient/healthcare consumer and those who care for and support patients/health care consumers. She develops trusted relationships and work in collaborative partnerships, bringing a consistent translational informatics role that deciphers and links clinical and technical perspectives. Her engagement in humble inquiry, continuous learning, and academic rigor drives my professional competence, innovation and creativity. Her mindful presence practice, willingness to provide and ask for (and accept) help, and a healthy sense of humor bring joy and insight to every interaction. She model Servant Leadership by co-creating healthier communities in and beyond my local world and sharing the story and strategies of that formation experience with others.

Less

Sharon E. Smith, MD, MBA

Dr. Smith is currently the Vice President and Chief Medical Officer in Prudential’s Health and

Benefits Center of Expertise. She has been in her role since June 2019, and works out of the company’s Newark, NJ headquarters. In her role Dr. Smith provides guidance on all clinical programs, supports programs that support the overall health and well-being of Prudential employees, and provides consultative support to the internal businesses. Dr. Smith serves as the clinical consultant to the Benefits strategy team, and advises on global health and safety for non-US employees.

Dr. Smith practiced Internal Medicine for over 20 years in diverse roles. She has held leadership positions in medical practices prior to coming to Prudential and continues clinical practice in a hospitalist role. She also represents Prudential on the National Committee for Quality Assurance.

Dr. Smith holds a Doctor of Medicine (MD) degree from Howard University College of Medicine, and a Master of Business Administration (MBA) degree from Columbia Business School. She is board certified in Internal Medicine, Lifestyle Medicine, and is a Certified Medical Review Officer. Dr. Smith has several professional affiliations and is a Fellow of the American College of Physicians.

Dr. Smith is active in the community and is a member of several organizations. She is a member of the North Manhattan Alumnae Chapter of Delta Sigma Theta Sorority, Inc. and is a working member on several sub-committees. Dr. Smith is active in the alumni associations of Binghamton University and Columbia Business School, where she is a co-chair of the Hermes Society and the Student Relief Fund and a founding member of the Columbia Women’s Circle. She is also a member of her local chapter of the National Council of Negro Women.

Less

Emily Stern, MD

Dr. Stern is an entrepreneur, radiologist, neuroscience researcher and expert in psychiatric neuroimaging,

with significant, broad leadership and management experience. Her passion for improving the lives of patients with neuropsychiatric disorders using biologically-based tools has led to the translation of her innovative and novel academic work into clinically useful solutions via Ceretype Neuromedicine, Inc. Prior to becoming a full-time CEO, she directed top neuroimaging research laboratories at Weill Cornell Medical College and Brigham and Women’s Hospital (BWH)/Harvard Medical School (HMS)for a total of 25 years, initiating and overseeing multiple, interdisciplinary scientific projects. She was also the Director of Functional and Molecular Neuroimaging at BWH/HMS, having built the programmatic and physical infrastructure for fMRI at BWH and was a Co-Chair of the Brigham Research Institute’s Neuroscience Research Center.

Less

Wei Sun, MBA

Wei Sun is the China Chief Product Officer of SingularityNET, where she provides strategic guidance

on product developments and commercial deployments of SingularityNET’s Blockchain and Artificial Intelligence technology, in the vertical markets including Healthcare and AIoT.

She is also the China founder and managing director of Humanity+, where she is passionately advocating the ethical use of emerging technologies in order to expand human capabilities. Additionally, she serves as a senior consultant in Artificial Intelligence at Counterpoint Research.

She was formally a product manager of Greater China at Advantech. Before that she was an MBA consultant to Nuance Communications, for successfully contribute to develop and launch its world’s first voice recognition mobile app, later bought by Apple and known as Siri.

Before Nuance, she was a research consultant in IDC Massachusetts headquarter, responsible for IDC’s global signature ranking product: FinTech 100. Before IDC she was a professional associate at The World Bank Treasury department, building and testing its financial systems for managing $20 billion assets in money market.

Her education background includes a full-time MBA degree from Boston University with the highest Dean’s scholarship and dual concentration in Finance and Marketing. She obtained her bachelor degree of Electrical Engineering from Carleton University in Canada, with a GPA 4.0/4.0 and a Chips Award.

Less

Paul Tang , MD, MS

Dr. Paul Tang is Adjunct Professor at the Clinical Excellence Research Center at Stanford University

and a practicing internist at the Palo Alto Medical Foundation. Most recently, he was Vice President, Chief Health Transformation Officer at IBM Watson Health, responsible for applying artificial intelligence technologies to improve the health and wellbeing of individuals and communities. He has served in executive administration roles in health systems for over 25 years. Prior to joining Watson Health, Dr. Tang was Vice President, Chief Innovation and Technology Officer at the Palo Alto Medical Foundation (PAMF), Sutter Health, directing the David Druker Center for Health Systems Innovation, a disruptive innovation center focused on grand challenges in health. Dr. Tang led one of the earliest implementations of an Electronic Health Record (EHR) system in the country in 1996, and in 2000, PAMF was the first to implement MyChart, a patient portal. Dr. Tang has dedicated his professional career to improving the quality of health care, innovative uses of health information technology (HIT), empowering patients through HIT, and shaping public policy to enhance health and health care in the US. He is an elected member of the National Academy of Medicine, and has served on numerous NAM study committees, including a patient-safety committee he chaired that published two reports: Patient Safety: A New Standard for Care, and Key Capabilities of an Electronic Health Record System. He is a member of the Health and Medicine Division committee of the National Academies of Science, Engineering, and Medicine.

Dr. Tang was co-chair of the federal Health Information Technology Policy committee from 2009-2017. He has served as board chair for several health informatics professional associations, including the American Medical Informatics Association (AMIA). He has served on the boards of AMIA, National Quality Forum, AcademyHealth, Computer-based Patient Record Institute, Joint Health Information Technology Alliance, NAM Board on Health Care Services, and National eHealth Collaborative. Dr. Tang is a recipient of the Nicholas E. Davies Award for Excellence in Computer-based Patient Record System Implementation, and the AMIA Don E. Detmer Award for Health Policy Contributions in Informatics. He currently holds one patent and has 16 patents pending. He has published numerous papers in medical informatics, appearing in New England Journal of Medicine, JAMA, Health Affairs, Annals of Internal Medicine, and Journal of the American Medical Informatics Association. He has delivered over 360 invited presentations (including 44 keynotes) to national and international organizations. Dr. Tang is a Fellow of the American College of Physicians, the American College of Medical Informatics, the College of Healthcare Information Management Executives, and the Healthcare Information and Management Systems Society.

He received his B.S. and M.S. in Electrical Engineering from Stanford University and his M.D. from the University of California, San Francisco. He completed his residency in internal medicine at Stanford University and is a board-certified practicing internist at the Palo Alto Medical Foundation.

Less

Fallon Ukpe, MD, MBA

Dr. Ukpe is an entrepreneur, venture capital investor, best selling author and speaker who is on a

mission to transform bold ideas into world-changing impact through business and philanthropy. She is Founder of The Vine, a technology, education and media company focused on inspiring the greatness within women worldwide as well as Managing Partner of Walnut & Sage, a firm focused on helping top tier professionals build high value brands, high growth companies and high impact non-profit organizations. Prior to launching into entrepreneurship and investing, she was a management consultant at McKinsey & Company, focused on serving healthcare and private equity clients. Fallon is a first generation Nigerian American and a native of Houston, Texas. She holds a Bachelor of Arts from Johns Hopkins University, a Doctor of Medicine from Duke University’s School of Medicine, and a Master of Business Administration from Duke University’s Fuqua School of Business. She is passionate about initiatives related to education and healthcare access as well as addressing issues related to gender and economic inequalities. Fallon often volunteers her time to mentor students and women entrepreneurs. She is an avid Duke Basketball fan who loves to travel and cook. She lives in the Los Angeles area with her Beagle named Riley.

Less

Pierre Vigilance, MD, MPH

Dr. Pierre Vigilance is a health executive with 20+ years experience working in non-profits, government,

academia, and strategy consulting. His primary expertise is in population health strategies and the social determinants of health and he has a notable background in organizational leadership, health policy,community engagement, and operations management.

As the Vice President for Population Health & Social Impact at ConsenSys Health (a spin-off of the Ethereum-based blockchain software technology company ConsenSys) he is responsible for developing partnerships, platforms and products designed to address the most challenging problems and transform the health of communities in the process. His advisory consultancy, HealthUp uses multi-sector partnerships to bring impact to each of their engagements. HealthUp works with family-offices, health systems, housing, education, and technology partners to create equity and justice-focused solutions to the health and wellness challenges faced by underserved communities. As the former health commissioner for Baltimore County and Washington, D.C., he led local responses to HIV, disease outbreaks (SARS in 2003, and H1N1 in 2009), and addressing preventable causes of death. He approaches the health challenges highlighted by COVID-19 with a primary focus on outreach and engagement strategies, community development, and technology.

After his time in government, he became the first Associate Dean for Practice at the George Washington University School of Public Health where he still teaches as an Adjunct Professor in the department of Health Policy & Management. He currently serves the Philadelphia community on the boards of Trinity Health Mid-Atlantic’s regional board, and Community Transformation Partners, a group established to bring a holistic equitable development approach to the transformation of a West Philadelphia middle neighborhood with buildings as amenities for economic and health mobility. In July 2021 he joined the national board of Volunteers of America.

Dr. Vigilance trained clinically in Emergency Medicine at Howard University Hospital and is a graduate of the Johns Hopkins University School of Medicine, and the Bloomberg School of Public Health. He often says he is on an evolving health journey and maintains his balance aided by healthy doses of prayer, good food, burpees, and music. In his spare time, he enjoys interviewing guests for his Apple podcast, Junctional Thinking. He currently resides with his family in Philadelphia, PA.

Less

Wendy Welch, MD, MBA, CHCQM

Dr. Welch serves as a Behavioral Health Medical Director for Centene Corporation, a diversified,

multi-national healthcare enterprise that provides a portfolio of services to government-sponsored healthcare programs, focusing on under-insured and uninsured individuals. She is also an Adjunct Associate Professor of Psychiatry at Atrium Health, where she teaches managed care literacy to faculty and residents. She was recently selected to serve as a Distinguished Mentor for Stanford University’s newly created Masters of Science in Clinical Informatics Management (MCiM).

She was previously the Chief Medical Officer for Cardinal Innovations Healthcare, a Medicaid specialty plan in North Carolina, and an Associate Professor of Psychiatry at Virginia Commonwealth University School of Medicine, where she was the Medical Director for Virginia’s Health Practitioners’ Monitoring Program. At the Virginia Treatment Center for Children and the Children’s Hospital of Richmond, she led specialty outpatient and consult services for adolescents with substance use disorders. She also served as the inaugural Behavioral Health Medical Director at Virginia Premier, the health plan arm of Virginia Commonwealth University Health System.

Her administrative experience includes serving as the Federal Vice President/Medical Director at ValueOptions Federal Services, where she was responsible for the behavioral health care of 3.3 million TRICARE beneficiaries, a health plan program for military personnel and their families. She also held the role of Director for Psychiatry and Behavioral Health for a regional health plan, leading clinical teams to meet national quality benchmarks while building high quality, fiscally sustainable healthcare delivery systems.

Less

Gabrielle Wolfson, MS

Ms. Wolfson is Senior Vice President, Chief Information & Digital Officer for Quest Diagnostics. She leads

technology, informatics and digital solutions at Quest, continuing the important work of the Healthcare Technology and Analytics Solutions (HTAS) team to empower consumers, providers, health systems and payers with critical insights to effectively manage population health. She also leads the Quanum Software and Sports Diagnostics businesses.

Prior to joining Quest in 2019, she served as Chief Information Officer for Xerox Corp. There Ms. Wolfson worked on transforming a high cost, complex technology landscape into a dynamic digital business, offering services on demand both internally and externally. She also developed a global data strategy to enable advanced analytics, artificial intelligence and machine learning to deliver business insights and improved customer services. Prior to Xerox, Ms. Wolfson was CIO at Wyndham Hotels and Resorts, Panasonic, Integra Life Sciences and Par Pharmaceutical. Earlier, she was a practice leader in life sciences and pharmaceutical industries at PricewaterhouseCoopers.

Ms. Wolfson holds a master’s degree in technology management from Columbia University and a bachelor’s degree in mathematics from Queens College in New York City. She is also a Member of the Governing Body of the Society of Information Management (SIM) and a frequent speaker at CIO executive forums.

Less

Sophia Yen, MD, MPH

Dr. Yen has a passion for making women's lives easier. Women have #BetterThingsToDo than to run to the

pharmacy each month and should not suffer from "pill anxiety" - the fear of running out of their prescription birth control. At Pandia Health, they solve this problem by bringing #BirthControl to women wherever they have internet and a mailbox. Dr. Yen loves to help educate women about #PeriodsOptional and men and women about #EmergencyContraception.

She is always happy to connect with companies serving women that want to co-market, women helping women, allies helping women.

Reproductive rights specialist/advocate. Adolescent Medicine specialist.

Board certified in Pediatrics and Adolescent Medicine.

Research regarding accuracy of health websites' information about reproductive health.

Research involving adolescents' and young adults' access to emergency contraception(EC) and patients' and MDs' knowledge about EC.

Research of undergraduates': knowledge of STDs/birth control and sexual behaviors.

Advocate for youth and children and women's rights.

Former Chairperson of the N. CA American Academy of Pediatric's Pediatric Obesity Interest Group

Clinical research of technology to treat obesity in children: using DDR.

Clinical research re: use of computers in patient rooms with internet access to increase patient satisfaction

Less

YiDing Yu, MD

Dr. Yu is a practicing physician and serial entrepreneur passionate about transforming the way we deliver

healthcare. Named woman entrepreneur of the year in 2018 by the Cartier Women’s Initiative Awards, YiDing is a skilled business operator and talented public speaker who has launched and scaled innovations across the healthcare ecosystem. Today, YiDing is Chief Medical Officer at Olive, a $1.5B healthcare AI company on a mission to unleash a trillion dollars of hidden potential within health care to improve the quality and quantity of human life. The company has raised $448M from Drive Capital, General Catalyst, Tiger Global, GV, and Sequoia, among others, and supports over 600 hospitals with its AI platforms.

Prior to Olive, YiDing was Chief Medical Officer at Verata Health, a leading healthcare AI company backed by BCBS Venture Partners, Bessemer, LRV Health, and 3M. At Verata, YiDing led marketing, customer operations, and payer partnerships, until Verata's acquisition by Olive in 2020. YiDing also founded and served as CEO of Twiage, an award-winning healthcare tech platform for emergency responders. YiDing began her career at Mass General Brigham, where she received the President’s Prize of Value-Based Healthcare Delivery. She’s also served as Chief Innovation Engineer of Atrius Health, a $2B health system in Boston, MA, where she launched telemedicine services for 700 physicians and 650,000 covered lives.

Today, YiDing continues to see patients, providing care in private practice as well as to American veterans through the Veterans Health Administration in Boston, MA.

Less

Kevin Schulman, MD, MBA

Director

Dr. Schulman was appointed as Professor of Medicine, Associate Chair of Business Development and Strategy in the

He is an elected member of ASCI and AAP. He is a graduate of Dartmouth College, the New York University School of Medicine, and The Wharton Health Care Management Program.

Less

Stanford Profile

Tatiana Hummel

Associate Director of Admissions & Administration

Tatiana joined the CERC team in November 2022 as the Associate Director of Admissions

& Administration for the Master of Science in Clinical Informatics Management (MCiM) program.

Prior to joining CERC, Tatiana was with San Francisco State University as the Associate Director for Graduate Enrollment and Recruitment focusing in diversified and inclusive admissions for almost a decade. She has extensive experience managing programs and with e-Discovery legal and technical project management. Tatiana received a Bachelor of Sciences in Business Administration from ESAG-UDESC in Brazil, and an MBA from SF State with emphasis in Sustainability and Project Management. She was born and grew up in Brazil and currently lives in San Francisco, CA with her husband and two daughters.

Less

James Gillespie, MA, PhD

Advisor

James is passionate about the application of advanced analytics, artificial intelligence,

and big data to address challenges and opportunities for companies and organizations in the biopharmaceutical, healthcare, medical, and technology sectors.

He is lead author of the recent book Patient-Centric Analytics in Health Care: Driving Value in Clinical Settings and Psychological Practice published by Rowman & Littlefield. In collaboration with several physicians, he is leading work on a new book AI and Machine Learning: Revolutionizing the Future of Healthcare and Medicine.

His education includes Northwestern University Kellogg School of Management, MA, PhD; Harvard University School of Law, JD; Princeton University Woodrow Wilson School of Public Policy, MPA; Massachusetts Institute of Technology, BS; Carnegie Mellon University Heinz School; and Rand Graduate School.

Less

Lisa Sandoval

Education Program Coordinator

Lisa joined the Stanford in June 2021 as an Administrative Associate to Dr. Kevin Schulman

and as the the Education Program Coordinator for the new Master of Science in Clinical Informatics Management (MCiM) program.

Prior to joining CERC, Lisa has worked in Clinical IT, Health Information Management, Case Management and Clinical Social Work within The Oregon Clinic and Lucile Packard Children’s Hospital at Stanford. Lisa received her Bachelor of Science degree in Child and Family Studies from Louisiana State University.

Less

Veronica Schulte

Education Program Specialist

Veronica recently transitioned into the role of Education Program Specialist for

the Master of Science in Clinical Informatics Management (MCiM) program. Currently, she supports the course content, bulletin, and Mentorship program workflow for the MCiM program. Veronica received her Bachelor of Science in Neuroscience and Biology with an emphasis in Biomedical Sciences from Santa Clara University.

Less

Stanford Profile